维百奥(北京)生物科技有限公司

首页 产品目录 产品目录(简版) 公司动态 企业认证 联系我们

Nebulabio Offers Series of Drug Antibody References

发布人:维百奥(北京)生物科技有限公司

发布日期:2025/2/21 16:18:58

 

Nebulabio Offers Series of Drug Antibody References

Learn More>> https://nebulabio.cn/en/index.php/hot/20632.html


Drug Antibody, also known as therapeutic antibodies, are biologically engineered proteins designed to specifically target and bind to antigens, such as proteins or cells, involved in diseases. Antibody drugs can be used to treat a wide range of conditions, including cancers, autoimmune diseases, infectious diseases, and inflammatory disorders. Molecular structures are including following types:

(1) Fully murine monoclonal antibodies and human-murine chimeric antibodies, such as Muromonab-CD3 (a fully murine monoclonal antibody) and Rituximab (a human-murine chimeric antibody);

(2) Antibodies with a higher degree of humanization, such as Trastuzumab and Nimotuzumab;

(3) Fully humanized antibodies, which are entirely encoded by human genes and significantly reduce immunogenicity, such as Adalimumab;

(4) Other forms of molecules, including antibody fusion proteins, antibody-drug conjugates, bispecific antibodies, small molecule antibody fragments and nanobodies.

 

Specificity: They bind to specific antigens with high precision, minimizing off-target effects.

Versatility: Antibody drugs can be engineered for various functions, such as blocking signaling pathways, recruiting immune cells, or delivering cytotoxic agents.

Diversity: They include monoclonal antibodies (mAbs), polyclonal antibodies, bispecific antibodies, antibody-drug conjugates (ADCs), and more.

Low Toxicity: Due to their specificity, they often have fewer side effects compared to traditional small-molecule drugs.

 

(1) Candidate Screening in Drug Development: Used to evaluate the activity, specificity, and affinity of candidate antibodies; Help understand the mechanism of action and biological functions of antibodies; Serve as a reference in antibody engineering to optimize structure and function.

(2) Production Process: Serve as a reference to optimize production conditions; Used to monitor consistency and stability during the production process.

(3) Quality Control: Assess the potency and activity of the drug; Detect impurities and degradation products; Evaluate the stability of the drug under different conditions.

(4) Pharmacodynamic Studies: Help determine safe and effective dosages; Serve as a reference to assess potential efficacy.

 

Nebula Biotechnology Co., Ltd. possesses an abundant collection of standard samples for drug antibody research, all of which are expressed through CHO or HEK293 cells. These samples boast a purity level exceeding 99%, with endotoxin levels lower than 1 EU/mg, making them suitable for various in vivo and in vitro validation tests.

 

Drug Antibody Name
Target
Product Name
Catalog Number
Enapotamab
AXL
Human ALX Antibody (Enapotamab, Research Use)
NBR-0001
Tilvestamab
AXL
Human ALX Antibody (Tilvestamab, Research Use)
NBR-0002
Alsevalimab
VTCN1
Human B7-H4 Antibody (Alsevalimab, Research Use)
NBR-0003
GSK2857916
TNFRSF17
Human BCMA Antibody (GSK2857916, Research Use)
NBR-0004
LFB patent anti-BDCA-2
BDCA-2
Human BDCA-2 Antibody (LFB patent anti-BDCA-2, Research Use)
NBR-0005
BIIB059
BDCA-2
Human BDCA-2 Antibody (BIIB059, Research Use)
NBR-0006
Inebilizumab
CD19
Human CD19 Antibody (Inebilizumab, Research Use)
NBR-0007
Tafasitamab
CD19
Human CD19 Antibody (Tafasitamab, Research Use)
NBR-0008
Rituximab
CD20
Human CD20 Antibody (Rituximab, Research Use)
NBR-0009
Obinutuzumab
CD20
Human CD20 Antibody (Obinutuzumab, Research Use)
NBR-0010
Cixutumumab
IGF-1R
Human IGF-1R Antibody (Cixutumumab, Research Use)
NBR-0011
Inotuzumab
CD22
Human CD22 Antibody (Inotuzumab, Research Use)
NBR-0012
Varlilumab
CD27
Human CD27 Antibody (Varlilumab, Research Use)
NBR-0013
Brentuximab
CD30
Human CD30 Antibody (Brentuximab, Research Use)
NBR-0014
Vadastuximab
CD33
Human CD33 Antibody (Vadastuximab, Research Use)
NBR-0015
Naratuximab
CD37
Human CD37 Antibody (Naratuximab, Research Use)
NBR-0016
Daratumumab
CD38
Human CD38 Antibody (Daratumumab, Research Use)
NBR-0017
Magenta patent anti-CD5
CD5
Human CD5 Antibody (Magenta patent anti-CD5, Research Use)
NBR-0018
Persongen patent anti-CD7
CD7
Human CD7 Antibody (Persongen patent anti-CD7, Research Use)
NBR-0019
Vorsetuzumab
CD27L / CD70
Human CD27L / CD70 Antibody (Vorsetuzumab, Research Use)
NBR-0020
Amivantamab
c-Met / HGFR
Human c-Met / HGFR Antibody (Amivantamab, Research Use)
NBR-0021
Telisotuzumab
c-Met / HGFR
Human c-Met / HGFR Antibody (Telisotuzumab, Research Use)
NBR-0022
Onartuzumab
c-Met / HGFR
Human c-Met / HGFR Antibody (Onartuzumab, Research Use)
NBR-0023
Pamrevlumab
CTGF
Human CTGF Antibody (Pamrevlumab, Research Use)
NBR-0024
Ipilimumab
CTLA-4
Human CTLA-4 Antibody (Ipilimumab, Research Use)
NBR-0025
Quetmolimab
CX3CL1
Human CX3CL1 Antibody (Quetmolimab, Research Use)
NBR-0026
Ulocuplumab
CXCR4
Human CXCR4 Antibody (Ulocuplumab, Research Use)
NBR-0027
MEN1309
DEC-205
Human DEC-205 Antibody (MEN1309, Research Use)
NBR-0028
CDX-1401
DEC-205
Human DEC-205 Antibody (CDX-1401, Research Use)
NBR-0029
Rovalpituzumab
DLL3
Human DLL3 Antibody (Rovalpituzumab, Research Use)
NBR-0030
Dragonfly patent anti-DLL3
DLL3
Human DLL3 Antibody (Dragonfly patent anti-DLL3, Research Use)
NBR-0031
Conatumumab
DR5
Human DR5 / TRAILR2 Antibody (Conatumumab, Research Use)
NBR-0032
Tigatuzumab
DR5 / TRAILR2
Human DR5 / TRAILR2 Antibody (Tigatuzumab, Research Use)
NBR-0033
Cetuximab
EGFR
Human EGFR Antibody (Cetuximab, Research Use)
NBR-0034
MEDI-547
EphA2
Human EphA2 Antibody (MEDI-547, Research Use)
NBR-0035
Sanofi Aventis patent anti-EphA2
EphA2
Human EphA2 Antibody (Sanofi Aventis patent anti-EphA2, Research Use)
NBR-0036
Rozanolixizumab
FcRn
Human FcRn Antibody (Rozanolixizumab, Research Use)
NBR-0037
Bemarituzumab
FGFR2
Human FGFR2 Antibody (Bemarituzumab, Research Use)
NBR-0038
Aprutumab
FGFR2
Human FGFR2 Antibody (Aprutumab, Research Use)
NBR-0039
Farletuzumab
FRA
Human FRA Antibody (Farletuzumab, Research Use)
NBR-0040
Mirvetuximab
FRA
Human FRA Antibody (Mirvetuximab, Research Use)
NBR-0041
Codrituzumab
GPC3
Human GPC3 Antibody (Codrituzumab, Research Use)
NBR-0042
Disitamab
HER2
Human HER2 Antibody (Disitamab, Research Use)
NBR-0043
Zanidatamab
HER2
Human HER2 Antibody (Zanidatamab, Research Use)
NBR-0044
Trastuzumab
HER2
Human HER2 Antibody (Trastuzumab, Research Use)
NBR-0045
Pertuzumab
HER2
Human HER2 Antibody (Pertuzumab, Research Use)
NBR-0046
Ordesekimab
IL-15
Human IL-15 Antibody (Ordesekimab, Research Use)
NBR-0047
Brodalumab
IL-17RA
Human IL-17RA Antibody (Brodalumab, Research Use)
NBR-0048
GSK 1070806
IL-18
Human IL-18 Antibody (GSK 1070806, Research Use)
NBR-0049
Nidanilimab
IL-1RAP
Human IL-1RAP Antibody (Nidanilimab, Research Use)
NBR-0050
Lilly patent anti-IL-21
IL-21
Human IL-21 Antibody (Lilly patent anti-IL-21, Research Use)
NBR-0051
Clazakizumab
IL-6
Human IL-6 Antibody (Clazakizumab, Research Use)
NBR-0052
Vobarilizumab
IL-6R
Human IL-6R Antibody (Vobarilizumab, Research Use)
NBR-0053
Sarilumab
IL-6R
Human IL-6R Antibody (Sarilumab, Research Use)
NBR-0054
Tocilizumab
IL-6R
Human IL-6R Antibody (Tocilizumab, Research Use)
NBR-0055
Lirilumab
KIR
Human KIR Antibody (Lirilumab, Research Use)
NBR-0056
Lacutamab
KIR3DL2
Human KIR3DL2 Antibody (Lacutamab, Research Use)
NBR-0057
MSC-1
LIF
Human LIF Antibody (MSC-1, Research Use)
NBR-0058
Merck patent anti-ILT3 complex
LILRB4
Human LILRB4 Antibody (Merck patent anti-ILT3 complex, Research Use)
NBR-0059
U.Texas patent anti-LILRB4
LILRB4
Human LILRB4 Antibody (U.Texas patent anti-LILRB4, Research Use)
NBR-0060
Lacnotuzumab
M-CSF
Human M-CSF Antibody (Lacnotuzumab, Research Use)
NBR-0061
Enfortumab
Nectin-4
Human Nectin-4 Antibody (Enfortumab, Research Use)
NBR-0062
Tesnatilimab
NKG2D
Human NKG2D Antibody (Tesnatilimab, Research Use)
NBR-0063
Oleclumab
NT5E
Human NT5E Antibody (Oleclumab, Research Use)
NBR-0064
Spartalizumab
PD-1
Human PD-1 Antibody (Spartalizumab, Research Use)
NBR-0065
Camrelizumab
PD-1
Human PD-1 Antibody (Camrelizumab, Research Use)
NBR-0066
Pembrolizumab
PD-1
Human PD-1 Antibody (Pembrolizumab, Research Use)
NBR-0067
Nivolumab
PD-1
Human PD-1 Antibody (Nivolumab, Research Use)
NBR-0068
MOR-8457
PDGFB
Human PDGFB Antibody (MOR-8457, Research Use)
NBR-0069
Avelumab
PD-L1
Human PD-L1 Antibody (Avelumab, Research Use)
NBR-0070
MDX-1105
PD-L1
Human PD-L1 Antibody (MDX-1105, Research Use)
NBR-0071
Atezolizumab
PD-L1
Human PD-L1 Antibody (Atezolizumab, Research Use)
NBR-0072
Durvalumab
PD-L1
Human PD-L1 Antibody (Durvalumab, Research Use)
NBR-0073
Genentech anti-PMEL17
PMEL17
Human PMEL17 Antibody (Genentech anti-PMEL17, Research Use)
NBR-0074
Novartis patent anti-PMEL17
PMEL17
Human PMEL17 Antibody (Novartis patent anti-PMEL17, Research Use)
NBR-0075
Inclacumab
P-Selectin
Human P-Selectin Antibody (Inclacumab, Research Use)
NBR-0076
Crizanlizumab
P-Selectin
Human P-Selectin Antibody (Crizanlizumab, Research Use)
NBR-0077
Neihulizumab
PSGL1
Human PSGL1 Antibody (Neihulizumab, Research Use)
NBR-0078
Rosopatamab
PSMA
Human PSMA Antibody (Rosopatamab, Research Use)
NBR-0079
Elezanumab
RGMA
Human RGMA Antibody (Elezanumab, Research Use)
NBR-0080
Zilovertamab
ROR1
Human ROR1 Antibody (Zilovertamab, Research Use)
NBR-0081
NC318
Siglec-15
Human Siglec-15 Antibody (NC318, Research Use)
NBR-0082
Lirentelimab
Siglec-8
Human Siglec-8 Antibody (Lirentelimab, Research Use)
NBR-0083
Elotuzumab
SLAMF7
Human SLAMF7 Antibody (Elotuzumab, Research Use)
NBR-0084
Tiragolumab
TIGIT
Human TIGIT Antibody (Tiragolumab, Research Use)
NBR-0085
Adalimumab
TNFa
Human TNFa Antibody (Adalimumab, Research Use)
NBR-0086
Infliximab
TNFa
Human TNFa Antibody (Infliximab, Research Use)
NBR-0087
Bevacizumab
VEGFA
Human VEGFA Antibody (Bevacizumab, Research Use)
NBR-0088
Ramucirumab
KDR / VEGFR2
Human KDR / VEGFR2 Antibody (Ramucirumab, Research Use)
NBR-0089
Utomilumab
4-1BB
Human 4-1BB Antibody (Utomilumab, Research Use)
NBR-0090
Urelumab
4-1BB
Human 4-1BB Antibody (Urelumab, Research Use)
NBR-0091
Abbvie patent anti-TNFSF9
4-1BBL
Human 4-1BBL Antibody (Abbvie patent anti-TNFSF9, Research Use)
NBR-0092
DS-6016a
ACVR1
Human ACVR1 Antibody (DS-6016a, Research Use)
NBR-0093
Ab-14E1
ACVR2A
Human ACVR2A Antibody (Ab-14E1, Research Use)
NBR-0094
Bimagrumab
ACVR2B
Human ACVR2B Antibody (Bimagrumab, Research Use)
NBR-0095
Praluzatamab
ALCAM
Human ALCAM Antibody (Praluzatamab, Research Use)
NBR-0096
AT002
ALCAM
Human ALCAM Antibody (AT002, Research Use)
NBR-0097
Ascrinvacumab
ALK-1
Human ALK-1 Antibody (Ascrinvacumab, Research Use)
NBR-0098
Cinpanemab
Alpha-synuclein
Human Alpha-synuclein Antibody (Cinpanemab, Research Use)
NBR-0099
Prasinezumab
Alpha-synuclein
Human Alpha-synuclein Antibody (Prasinezumab, Research Use)
NBR-0100
Nesvacumab
Angiopoietin-2
Human Angiopoietin-2 Antibody (Nesvacumab, Research Use)
NBR-0101
Evinacumab
Angiopoietin-like3
Human Angiopoietin-like3 Antibody (Evinacumab, Research Use)
NBR-0102
Dezamizumab
APCS
Human APCS Antibody (Dezamizumab, Research Use)
NBR-0103
BION-1301
APRIL
Human APRIL Antibody (BION-1301, Research Use)
NBR-0104
Enoblituzumab
B7-H3
Human B7-H3 Antibody (Enoblituzumab, Research Use)
NBR-0105
Onvatilimab
B7-H5 / VISTA
Human B7-H5 / VISTA Antibody (Onvatilimab, Research Use)
NBR-0106
Dartmouth patent anti-B7-H6
B7-H6
Human B7-H6 Antibody (Dartmouth patent anti-B7-H6, Research Use)
NBR-0107
Belimumab
BAFF
Human BAFF Antibody (Belimumab, Research Use)
NBR-0108
U.Toronto patent anti-Bax
Bcl-2
Human Bcl-2 Antibody (U.Toronto patent anti-Bax, Research Use)
NBR-0109
RG7992
Beta-Klotho
Human Beta-Klotho Antibody (RG7992, Research Use)
NBR-0110
NGM313
Beta-Klotho
Human Beta-Klotho Antibody (NGM313, Research Use)
NBR-0111
XmAb 5592
BST2
Human BST2 Antibody (XmAb 5592, Research Use)
NBR-0112
Sutimlimab
C1s
Human C1s Antibody (Sutimlimab, Research Use)
NBR-0113
G2_anti-C5aR
C5aR
Human C5aR Antibody (G2_anti-C5aR, Research Use)
NBR-0114
HKT288+D116
Cadherin-6
Human Cadherin-6 Antibody (HKT288+D116, Research Use)
NBR-0115
Girentuximab
CAIX
Human CAIX Antibody (Girentuximab, Research Use)
NBR-0116
Fsn0503h
Cathepsin S
Human Cathepsin S Antibody (Fsn0503h, Research Use)
NBR-0117
VLST-002
CCL5
Human CCL5 Antibody (VLST-002, Research Use)
NBR-0118
Plozalizumab
CCR2
Human CCR2 Antibody (Plozalizumab, Research Use)
NBR-0119
Mogamulizumab
CCR4
Human CCR4 Antibody (Mogamulizumab, Research Use)
NBR-0120
R707
CCR7
Human CCR7 Antibody (R707, Research Use)
NBR-0121
LOP628
CD117
Human CD117 Antibody (LOP628, Research Use)
NBR-0122
SNG-CD123A
IL-3RA
Human IL-3RA Antibody (SNG-CD123A, Research Use)
NBR-0123
Talacotuzumab
IL-3RA
Human IL-3RA Antibody (Talacotuzumab, Research Use)
NBR-0124
Forerunner patent anti-Prominin-1
CD133
Human CD133 Antibody (Forerunner patent anti-Prominin-1, Research Use)
NBR-0125
Samalizumab
CD200
Human CD200 Antibody (Samalizumab, Research Use)
NBR-0126
Janssen patent anti-CD200R1
CD200R
Human CD200R Antibody (Janssen patent anti-CD200R1, Research Use)
NBR-0127
Basiliximab
CD25 / IL-1RA
Human CD25 / IL-1RA Antibody (Basiliximab, Research Use)
NBR-0128
Belantamab
BCMA
Human BCMA Antibody (Belantamab, Research Use)
NBR-0129
VIB9600
CD32a
Human CD32a Antibody (VIB9600, Research Use)
NBR-0130
TTX-030
CD39
Human CD39 Antibody (TTX-030, Research Use)
NBR-0131
Bleselumab
CD40
Human CD40 Antibody (Bleselumab, Research Use)
NBR-0132
Sotigalimab
CD40
Human CD40 Antibody (Sotigalimab, Research Use)
NBR-0133
Dacetuzumab
CD40
Human CD40 Antibody (Dacetuzumab, Research Use)
NBR-0134
FOR46
CD46
Human CD46 Antibody (FOR46, Research Use)
NBR-0135
Magrolimab
CD47
Human CD47 Antibody (Magrolimab, Research Use)
NBR-0136
CC-90002
CD47
Human CD47 Antibody (CC-90002, Research Use)
NBR-0137
Alemtuzumab
CD52
Human CD52 Antibody (Alemtuzumab, Research Use)
NBR-0138
Lorvotuzumab
CD56
Human CD56 Antibody (Lorvotuzumab, Research Use)
NBR-0139
Genefrontier patent anti-CD69
CD69
Human CD69 Antibody (Genefrontier patent anti-CD69, Research Use)
NBR-0140
Polatuzumab
CD79b / Ig B
Human CD79b / Ig B Antibody (Polatuzumab, Research Use)
NBR-0141
U.California patent anti-CDCP1
CDCP1
Human CDCP1 Antibody (U.California patent anti-CDCP1, Research Use)
NBR-0142
Labetuzumab
CEA
Human CEA Antibody (Labetuzumab, Research Use)
NBR-0143
CM-24
CEACAM1
Human CEACAM1 Antibody (CM-24, Research Use)
NBR-0144
NEO-201
CEACAM6
Human CEACAM6 Antibody (NEO-201, Research Use)
NBR-0145
Brown U. patent anti-CHI3L1
Chitinase3-like1
Human Chitinase3-like1 Antibody (Brown U. patent anti-CHI3L1, Research Use)
NBR-0146
GSK3050002
CK-B4
Human CK-B4 Antibody (GSK3050002, Research Use)
NBR-0147
FA19-1
CLCP1
Human CLCP1 Antibody (FA19-1, Research Use)
NBR-0148
Zolbetuximab
CLDN18
Human CLDN18 Antibody (Zolbetuximab, Research Use)
NBR-0149
IMAB027
CLDN6
Human CLDN6 Antibody (IMAB027, Research Use)
NBR-0150
Tepoditamab
CLEC12A
Human CLEC12A Antibody (Tepoditamab, Research Use)
NBR-0151
Scripps Korea patent anti-CLEC14A
CLEC14A
Human CLEC14A Antibody (Scripps Korea patent anti-CLEC14A, Research Use)
NBR-0152
Oxford Bio patent anti-CRTAM
CRTAM
Human CRTAM Antibody (Oxford Bio patent anti-CRTAM, Research Use)
NBR-0153
Cabiralizumab
CSF1R
Human CSF1R Antibody (Cabiralizumab, Research Use)
NBR-0154
Med. Bio. Labs patent anti-CXADR
CXADR
Human CXADR Antibody (Med. Bio. Labs patent anti-CXADR, Research Use)
NBR-0155
Eldelumab
CXCL10
Human CXCL10 Antibody (Eldelumab, Research Use)
NBR-0156
Novimmune patent anti-CXCL9
CXCL9
Human CXCL9 Antibody (Novimmune patent anti-CXCL9, Research Use)
NBR-0157
SAR113244
CXCR5
Human CXCR5 Antibody (SAR113244, Research Use)
NBR-0158
INSERM patent anti-DC-SIGN
DC-SIGN
Human DC-SIGN Antibody (INSERM patent anti-DC-SIGN, Research Use)
NBR-0159
Baylor patent anti-Dectin-1
Dectin-1
Human Dectin-1 Antibody (Baylor patent anti-Dectin-1, Research Use)
NBR-0160
BHQ-880
DKK1
Human DKK1 Antibody (BHQ-880, Research Use)
NBR-0161
Demcizumab
DLL4
Human DLL4 Antibody (Demcizumab, Research Use)
NBR-0162
Navicixizumab
DLL4
Human DLL4 Antibody (Navicixizumab, Research Use)
NBR-0163
Abbvie patent anti-TNFRSF21
DR6
Human DR6 Antibody (Abbvie patent anti-TNFRSF21, Research Use)
NBR-0164
Citatuzumab
EPCAM
Human EPCAM Antibody (Citatuzumab, Research Use)
NBR-0165
Genentech patent anti-EphB2
EphB2
Human EphB2 Antibody (Genentech patent anti-EphB2, Research Use)
NBR-0166
Morphosys patent anti-EphB4
EphB4
Human EphB4 Antibody (Morphosys patent anti-EphB4, Research Use)
NBR-0167
VasGene patent anti-EphB4
EphB4
Human EphB4 Antibody (VasGene patent anti-EphB4, Research Use)
NBR-0168
Roche patent anti-Her3 / Her4
ErbB4
Human ErbB4 Antibody (Roche patent anti-Her3 / Her4, Research Use)
NBR-0169
Abbott patent anti-EPO Receptor
ErythropoietinR
Human ErythropoietinR Antibody (Abbott patent anti-EPO Receptor, Research Use)
NBR-0170
Sibrotuzumab
FAP
Human FAP Antibody (Sibrotuzumab, Research Use)
NBR-0171
LY2928057
Ferroportin
Human Ferroportin Antibody (LY2928057, Research Use)
NBR-0172
Amgen patent anti-Ferroportin
Ferroportin
Human Ferroportin Antibody (Amgen patent anti-Ferroportin, Research Use)
NBR-0173
1A6
FGF19
Human FGF19 Antibody (1A6, Research Use)
NBR-0174
HuGAL-F2
FGF2
Human FGF2 Antibody (HuGAL-F2, Research Use)
NBR-0175
LY3076226
FGFR3
Human FGFR3 Antibody (LY3076226, Research Use)
NBR-0176
Vofatamab
FGFR3
Human FGFR3 Antibody (Vofatamab, Research Use)
NBR-0177
U3-1784
FGFR4
Human FGFR4 Antibody (U3-1784, Research Use)
NBR-0178
L19-TNF
Fibronectin
Human Fibronectin Antibody (L19-TNF, Research Use)
NBR-0179
IMC-EB10
FLT3
Human FLT3 Antibody (IMC-EB10, Research Use)
NBR-0180
U.Toronto patent anti-FZD7
Frizzled-7
Human Frizzled-7 Antibody (U.Toronto patent anti-FZD7, Research Use)
NBR-0181
Crotedumab
GCGR
Human GCGR Antibody (Crotedumab, Research Use)
NBR-0182
Volagidemab
GCGR
Human GCGR Antibody (Volagidemab, Research Use)
NBR-0183
CSL patent anti-G-CSFR
G-CSFR
Human G-CSFR Antibody (CSL patent anti-G-CSFR, Research Use)
NBR-0184
Amgen patent anti-GIPR
GIPR
Human GIPR Antibody (Amgen patent anti-GIPR, Research Use)
NBR-0185
Ragifilimab
GITR
Human GITR Antibody (Ragifilimab, Research Use)
NBR-0186
Mavrilimumab
GM-CSF2RA
Human GM-CSF2RA Antibody (Mavrilimumab, Research Use)
NBR-0187
Regeneron patent anti-GP130 / LEPR
Gp130
Human Gp130 Antibody (Regeneron patent anti-GP130 / LEPR, Research Use)
NBR-0188
KRN330
GPA33
Human GPA33 Antibody (KRN330, Research Use)
NBR-0189
Glembatumumab
GPNMB
Human GPNMB Antibody (Glembatumumab, Research Use)
NBR-0190
BNC101
GPR49
Human GPR49 Antibody (BNC101, Research Use)
NBR-0191
Petosemtamab
GPR49
Human GPR49 Antibody (Petosemtamab, Research Use)
NBR-0192
Talquetamab
GPRC5D
Human GPRC5D Antibody (Talquetamab, Research Use)
NBR-0193
UCB patent anti-Gremlin-1
Gremlin
Human Gremlin Antibody (UCB patent anti-Gremlin-1, Research Use)
NBR-0194
KHK patent anti-Haptoglobin
Haptoglobin
Human Haptoglobin Antibody (KHK patent anti-Haptoglobin, Research Use)
NBR-0195
KHK2866
HB-EGF
Human HB-EGF Antibody (KHK2866, Research Use)
NBR-0196
U3-1565
HB-EGF
Human HB-EGF Antibody (U3-1565, Research Use)
NBR-0197
Patritumab
HER3
Human HER3 Antibody (Patritumab, Research Use)
NBR-0198
Seribantumab
HER3
Human HER3 Antibody (Seribantumab, Research Use)
NBR-0199
Ficlatuzumab
HGF / SF
Human HGF / SF Antibody (Ficlatuzumab, Research Use)
NBR-0200
Rilotumumab
HGF / SF
Human HGF / SF Antibody (Rilotumumab, Research Use)
NBR-0201
Emibetuzumab
c-Met / HGFR
Human c-Met / HGFR Antibody (Emibetuzumab, Research Use)
NBR-0202
Vopratelimab
ICOS
Human ICOS Antibody (Vopratelimab, Research Use)
NBR-0203
Feladilimab
ICOS
Human ICOS Antibody (Feladilimab, Research Use)
NBR-0204
LIMR patent anti-IDO2
IDO2
Human IDO2 Antibody (LIMR patent anti-IDO2, Research Use)
NBR-0205
Rontalizumab
IFNA1
Human IFNA1 Antibody (Rontalizumab, Research Use)
NBR-0206
Sifalimumab
IFNA1
Human IFNA1 Antibody (Sifalimumab, Research Use)
NBR-0207
Xentuzumab
IGF-1
Human IGF-1 Antibody (Xentuzumab, Research Use)
NBR-0208
Teprotumumab
IGF-1R
Human IGF-1R Antibody (Teprotumumab, Research Use)
NBR-0209
Ustekinumab
IL-12
Human IL-12 Antibody (Ustekinumab, Research Use)
NBR-0210
Anrukinzumab
IL-13
Human IL-13 Antibody (Anrukinzumab, Research Use)
NBR-0211
Wake Forest U. patent anti-IL-13RA2
IL-13RA2
Human IL-13RA2 Antibody (Wake Forest U. patent anti-IL-13RA2, Research Use)
NBR-0212
MOR106
IL-17C
Human IL-17C Antibody (MOR106, Research Use)
NBR-0213
AMG 108
IL-1R1
Human IL-1R1 Antibody (AMG 108, Research Use)
NBR-0214
Spesolimab
IL-1RL2
Human IL-1RL2 Antibody (Spesolimab, Research Use)
NBR-0215
Imsidolimab
IL-1RL2
Human IL-1RL2 Antibody (Imsidolimab, Research Use)
NBR-0216
Fletikumab
IL-20
Human IL-20 Antibody (Fletikumab, Research Use)
NBR-0217
Cheng Kung U. patent anti-IL-20R1
IL-20RA
Human IL-20RA Antibody (Cheng Kung U. patent anti-IL-20R1, Research Use)
NBR-0218
Fezakinumab
IL-22
Human IL-22 Antibody (Fezakinumab, Research Use)
NBR-0219
Guselkumab
IL-23
Human IL-23 Antibody (Guselkumab, Research Use)
NBR-0220
Tildrakizumab
IL-23P19
Human IL-23P19 Antibody (Tildrakizumab, Research Use)
NBR-0221
Singapore ASTR patent anti-IL-2R beta / IL-2R gamma 
IL-2RB
Human IL-2RB Antibody (Singapore ASTR patent anti-IL-2R beta / IL-2R gamma , Research Use)
NBR-0222
Daclizumab
IL-2RA
Human IL-2RA Antibody (Daclizumab, Research Use)
NBR-0223
Nemolizumab
IL-31RA
Human IL-31RA Antibody (Nemolizumab, Research Use)
NBR-0224
Etokimab
IL-33
Human IL-33 Antibody (Etokimab, Research Use)
NBR-0225
Pascolizumab
IL-4
Human IL-4 Antibody (Pascolizumab, Research Use)
NBR-0226
Dupilumab
IL-4RA
Human IL-4RA Antibody (Dupilumab, Research Use)
NBR-0227
Mepolizumab
IL-5
Human IL-5 Antibody (Mepolizumab, Research Use)
NBR-0228
Benralizumab
IL-5RA
Human IL-5RA Antibody (Benralizumab, Research Use)
NBR-0229
Lusvertikimab
IL-7RA
Human IL-7RA Antibody (Lusvertikimab, Research Use)
NBR-0230
HuMax-IL8
IL-8
Human IL-8 Antibody (HuMax-IL8, Research Use)
NBR-0231
Enokizumab 
IL-9
Human IL-9 Antibody (Enokizumab , Research Use)
NBR-0232
Innate patent anti-KIR2DL  
KIR2DL1
Human KIR2DL1 Antibody (Innate patent anti-KIR2DL  , Research Use)
NBR-0233
Relatlimab
LAG3
Human LAG3 Antibody (Relatlimab, Research Use)
NBR-0234
Brigham and Womens anti-LAP
LAP
Human LAP Antibody (Brigham and Womens anti-LAP, Research Use)
NBR-0235
Mibavademab
LEPR
Human LEPR Antibody (Mibavademab, Research Use)
NBR-0236
MB 311
LeY
Human LeY Antibody (MB 311, Research Use)
NBR-0237
JTX-8064
LILRB2
Human LILRB2 Antibody (JTX-8064, Research Use)
NBR-0238
Simtuzumab
LOXL2
Human LOXL2 Antibody (Simtuzumab, Research Use)
NBR-0239
Ontamalimab
MAdCAM-1
Human MAdCAM-1 Antibody (Ontamalimab, Research Use)
NBR-0240
Refanezumab
MAG
Human MAG Antibody (Refanezumab, Research Use)
NBR-0241
CT Atlantic patent anti-MAGE-A3
MAGE-A3
Human MAGE-A3 Antibody (CT Atlantic patent anti-MAGE-A3, Research Use)
NBR-0242
Narsoplimab
MASP-2
Human MASP-2 Antibody (Narsoplimab, Research Use)
NBR-0243
RGX-019
MERTK
Human MERTK Antibody (RGX-019, Research Use)
NBR-0244
Amatuximab
Mesothelin
Human Mesothelin Antibody (Amatuximab, Research Use)
NBR-0245
Anetumab
Mesothelin
Human Mesothelin Antibody (Anetumab, Research Use)
NBR-0246
Imalumab
MIF
Human MIF Antibody (Imalumab, Research Use)
NBR-0247
Andecaliximab
MMP-9
Human MMP-9 Antibody (Andecaliximab, Research Use)
NBR-0248
Ensituximab
MU5AC
Human MU5AC Antibody (Ensituximab, Research Use)
NBR-0249
Clivatuzumab
MUC1
Human MUC1 Antibody (Clivatuzumab, Research Use)
NBR-0250
Oregovomab
MUC16
Human MUC16 Antibody (Oregovomab, Research Use)
NBR-0251
Sofituzumab
CA125
Human CA125 Antibody (Sofituzumab, Research Use)
NBR-0252
Landogrozumab
Myostatin
Human Myostatin Antibody (Landogrozumab, Research Use)
NBR-0253
Trevogrumab
Myostatin
Human Myostatin Antibody (Trevogrumab, Research Use)
NBR-0254
Fulranumab
NGF
Human NGF Antibody (Fulranumab, Research Use)
NBR-0255
Tanezumab
NGF
Human NGF Antibody (Tanezumab, Research Use)
NBR-0256
Monalizumab
NKG2A
Human NKG2A Antibody (Monalizumab, Research Use)
NBR-0257
Ozanezumab
Nogo-A
Human Nogo-A Antibody (Ozanezumab, Research Use)
NBR-0258
Brontictuzumab
Notch1
Human Notch1 Antibody (Brontictuzumab, Research Use)
NBR-0259
Vesencumab
NRP1
Human NRP1 Antibody (Vesencumab, Research Use)
NBR-0260
Tavolixizumab
OX40
Human OX40 Antibody (Tavolixizumab, Research Use)
NBR-0261
Oxelumab
OX40L
Human OX40L Antibody (Oxelumab, Research Use)
NBR-0262
Alirocumab
PCSK9
Human PCSK9 Antibody (Alirocumab, Research Use)
NBR-0263
Thrombogenics patent anti-PDGF-C
PDGFC
Human PDGFC Antibody (Thrombogenics patent anti-PDGF-C, Research Use)
NBR-0264
Tovetumab
PDGFRA
Human PDGFRA Antibody (Tovetumab, Research Use)
NBR-0265
Olaratumab
PDGFRA
Human PDGFRA Antibody (Olaratumab, Research Use)
NBR-0266
Rinucumab
PDGFRB
Human PDGFRB Antibody (Rinucumab, Research Use)
NBR-0267
Novo Nordisk patent anti-PGLYRP1
PGLYRP1
Human PGLYRP1 Antibody (Novo Nordisk patent anti-PGLYRP1, Research Use)
NBR-0268
Diaccurate patent anti-sPLA2-GIB
PLA2G1B
Human PLA2G1B Antibody (Diaccurate patent anti-sPLA2-GIB, Research Use)
NBR-0269
Eureka patent anti-PRAME
PRAME
Human PRAME Antibody (Eureka patent anti-PRAME, Research Use)
NBR-0270
AGS-1C4D4
PSCA
Human PSCA Antibody (AGS-1C4D4, Research Use)
NBR-0271
GSK4381562
PVRIG
Human PVRIG Antibody (GSK4381562, Research Use)
NBR-0272
COM701
PVRIG
Human PVRIG Antibody (COM701, Research Use)
NBR-0273
XT-M4
RAGE
Human RAGE Antibody (XT-M4, Research Use)
NBR-0274
Denosumab
RANKL
Human RANKL Antibody (Denosumab, Research Use)
NBR-0275
Narnatumab
RON
Human RON Antibody (Narnatumab, Research Use)
NBR-0276
Oncomed patent anti-RSPO1
RSPO1
Human RSPO1 Antibody (Oncomed patent anti-RSPO1, Research Use)
NBR-0277
Rosmantuzumab
RSPO3
Human RSPO3 Antibody (Rosmantuzumab, Research Use)
NBR-0278
Setrusumab
Sclerostin
Human Sclerostin Antibody (Setrusumab, Research Use)
NBR-0279
Romosozumab
Sclerostin
Human Sclerostin Antibody (Romosozumab, Research Use)
NBR-0280
Pepinemab
SEMA4D
Human SEMA4D Antibody (Pepinemab, Research Use)
NBR-0281
Hospital for Sick Children patent anti-SIRPA
SIRPA
Human SIRPA Antibody (Hospital for Sick Children patent anti-SIRPA, Research Use)
NBR-0282
KWAR23
SIRPG
Human SIRPG Antibody (KWAR23, Research Use)
NBR-0283
Bexmarilimab
STAB1
Human STAB1 Antibody (Bexmarilimab, Research Use)
NBR-0284
Vandortuzumab
STEAP1
Human STEAP1 Antibody (Vandortuzumab, Research Use)
NBR-0285
Indatuximab
Syndecan-1
Human Syndecan-1 Antibody (Indatuximab, Research Use)
NBR-0286
Gosuranemab
Tau
Human Tau Antibody (Gosuranemab, Research Use)
NBR-0287
Semorinemab
Tau
Human Tau Antibody (Semorinemab, Research Use)
NBR-0288
Tisotumab
TF
Human TF Antibody (Tisotumab, Research Use)
NBR-0289
SRK181
TGFb
Human TGFb Antibody (SRK181, Research Use)
NBR-0290
M7824
TGFb
Human TGFb Antibody (M7824, Research Use)
NBR-0291
Sabatolimab
TIM-3 / HAVCR2
Human TIM-3 / HAVCR2 Antibody (Sabatolimab, Research Use)
NBR-0292
Tomaralimab
TLR2
Human TLR2 Antibody (Tomaralimab, Research Use)
NBR-0293
C1068
TLR3
Human TLR3 Antibody (C1068, Research Use)
NBR-0294
Mapatumumab
TRAIL-R1
Human TRAIL-R1 Antibody (Mapatumumab, Research Use)
NBR-0295
GBR 900
TrkA
Human TrkA Antibody (GBR 900, Research Use)
NBR-0296
Sacituzumab
TROP-2
Human TROP-2 Antibody (Sacituzumab, Research Use)
NBR-0297
Enavatuzumab
TWEAKR
Human TWEAKR Antibody (Enavatuzumab, Research Use)
NBR-0298
ELB031
TYRO3
Human TYRO3 Antibody (ELB031, Research Use)
NBR-0299
Timolumab
VAP-1
Human VAP-1 Antibody (Timolumab, Research Use)
NBR-0300
Icrucumab
FLT1 / VEGFR1
Human FLT1 / VEGFR1 Antibody (Icrucumab, Research Use)
NBR-0301
DS-6000a
CDH6
Human CDH6 Antibody (DS-6000a, Research Use)
NBR-0302
Tabituximab
Frizzled-10
Human Frizzled-10 Antibody (Tabituximab, Research Use)
NBR-0303
Itolizumab
CD6
Human CD6 Antibody (Itolizumab, Research Use)
NBR-0304
Asclepius Technology patent anti-Robo1 CAR
Robo1
Human Robo1 Antibody (Asclepius Technology patent anti-Robo1 CAR, Research Use)
NBR-0305
Murlentamab
AMHR2
Human AMHR2 Antibody (Murlentamab, Research Use)
NBR-0306
Idactamab
ASCT2
Human ASCT2 Antibody (Idactamab, Research Use)
NBR-0307
Carotuximab
CD105
Human CD105 Antibody (Carotuximab, Research Use)
NBR-0308
Regeneron patent anti-CD48
CD48
Human CD48 Antibody (Regeneron patent anti-CD48, Research Use)
NBR-0309
SC-005
Melanotransferrin
Human Melanotransferrin Antibody (SC-005, Research Use)
NBR-0310
Ianalumab
BAFFR
Human BAFFR Antibody (Ianalumab, Research Use)
NBR-0311
GFB-024
CB1
Human CB1 Antibody (GFB-024, Research Use)
NBR-0312
Erenumab
CGRPR
Human CGRPR Antibody (Erenumab, Research Use)
NBR-0313
Garadacimab
Factor XII
Human Factor XII Antibody (Garadacimab, Research Use)
NBR-0314
Burosumab
FGF23
Human FGF23 Antibody (Burosumab, Research Use)
NBR-0315
BMS-986012
Fucosyl GM1
Human Fucosyl GM1 Antibody (BMS-986012, Research Use)
NBR-0316
Anifrolumab
IFNAR-1
Human IFNAR-1 Antibody (Anifrolumab, Research Use)
NBR-0317
ARGX-112
IL-22RA
Human IL-22RA Antibody (ARGX-112, Research Use)
NBR-0318
Daxdilimab
ILT7
Human ILT7 Antibody (Daxdilimab, Research Use)
NBR-0319
Lanadelumab
Kallikrein
Human Kallikrein Antibody (Lanadelumab, Research Use)
NBR-0320
 Orticumab
oxLDL
Human oxLDL Antibody ( Orticumab, Research Use)
NBR-0321
CTX-2026
Butyrophilin
Human Butyrophilin Antibody (CTX-2026, Research Use)
NBR-0322
ARGX-117
C2
Human C2 Antibody (ARGX-117, Research Use)
NBR-0323
NGM621
C3
Human C3 Antibody (NGM621, Research Use)
NBR-0324
Atibuclimab
CD14
Human CD14 Antibody (Atibuclimab, Research Use)
NBR-0325
AB-16B5
Clusterin
Human Clusterin Antibody (AB-16B5, Research Use)
NBR-0326
CSL324
G-CSF
Human G-CSF Antibody (CSL324, Research Use)
NBR-0327
DS-6157
GPR20
Human GPR20 Antibody (DS-6157, Research Use)
NBR-0328
OS2966
Integrin B1
Human Integrin B1 Antibody (OS2966, Research Use)
NBR-0329
NP137
Netrin 1
Human Netrin 1 Antibody (NP137, Research Use)
NBR-0330
 Bavituximab
Phosphatidylserine
Human Phosphatidylserine Antibody ( Bavituximab, Research Use)
NBR-0331
CSL346
VEGFB
Human VEGFB Antibody (CSL346, Research Use)
NBR-0332
Garetosmab
Activin A
Human Activin A Antibody (Garetosmab, Research Use)
NBR-0333
Enibarcimab
Adrenomedullin
Human Adrenomedullin Antibody (Enibarcimab, Research Use)
NBR-0334
ANX005
C1q
Human C1q Antibody (ANX005, Research Use)
NBR-0335
CSL311
CSF2RB
Human CSF2RB Antibody (CSL311, Research Use)
NBR-0336
NGM120
GFRAL
Human GFRAL Antibody (NGM120, Research Use)
NBR-0337
Glenzocimab
GPVI
Human GPVI Antibody (Glenzocimab, Research Use)
NBR-0338
ATH3G10
Phosphorylcholine
Human Phosphorylcholine Antibody (ATH3G10, Research Use)
NBR-0339
M6495
ADAMTS5
Human ADAMTS5 Antibody (M6495, Research Use)
NBR-0340
MK-6105
IL-13RA1
Human IL-13RA1  Antibody (MK-6105, Research Use)
NBR-0341
Bapotulimab
ILDR2
Human ILDR2 Antibody (Bapotulimab, Research Use)
NBR-0342
Indusatumab
GCC
Human GCC Antibody (Indusatumab, Research Use)
NBR-0343
STX-100
Integrin AV & B6
Human Integrin AV & B6 Antibody (STX-100, Research Use)
NBR-0344
Milatuzumab
MHC
Human MHC Antibody (Milatuzumab, Research Use)
NBR-0345
 Lifastuzumab
NaPi2b
Human NaPi2b Antibody ( Lifastuzumab, Research Use)
NBR-0346
MGD007
A33
Human A33 Antibody (MGD007, Research Use)
NBR-0347
Apamistamab
CD45
Human CD45 Antibody (Apamistamab, Research Use)
NBR-0348
Emicizumab
Factor IX
Human Factor IX Antibody (Emicizumab, Research Use)
NBR-0349
 Vedolizumab
Integrin A4 & B7
Human Integrin A4 & B7 Antibody ( Vedolizumab, Research Use)
NBR-0350
MVT-5873
Sialyl-Lewis A
Human Sialyl-Lewis A Antibody (MVT-5873, Research Use)
NBR-0351
INSERM patent anti-vWF
vWF
Human vWF Antibody (INSERM patent anti-vWF, Research Use)
NBR-0352
Genzyme patent anti-CXCR3
CXCR3
Human CXCR3 Antibody (Genzyme patent anti-CXCR3, Research Use)
NBR-0353
TA136
TPOR
Human TPOR Antibody (TA136, Research Use)
NBR-0354
Genentech patent anti-Tryptase Beta 1
TPSAB1
Human TPSAB1 Antibody (Genentech patent anti-Tryptase Beta 1, Research Use)
NBR-0355
Genentech patent anti-Bv8
Bv8
Human Bv8 Antibody (Genentech patent anti-Bv8, Research Use)
NBR-0356
M116
CCL17
Human CCL17 Antibody (M116, Research Use)
NBR-0357
KHK patent anti-CRTH2
CRTh2
Human CRTh2 Antibody (KHK patent anti-CRTH2, Research Use)
NBR-0358
Cureab patent anti-GP73
GP73
Human GP73 Antibody (Cureab patent anti-GP73, Research Use)
NBR-0359
Regeneron patent anti-GREM1
GREM1
Human GREM1 Antibody (Regeneron patent anti-GREM1, Research Use)
NBR-0360
Erlizumab
Integrin B2
Human Integrin B2 Antibody (Erlizumab, Research Use)
NBR-0361
Abbott patent anti-NGR
NGR
Human NGR Antibody (Abbott patent anti-NGR, Research Use)
NBR-0362
Lilly patent anti-PACAP
PACAP-38
Human PACAP-38 Antibody (Lilly patent anti-PACAP, Research Use)
NBR-0363
Novelmed patent anti-Properdin
Properdin
Human Properdin Antibody (Novelmed patent anti-Properdin, Research Use)
NBR-0364
DISC-0974
RGM C
Human RGM C Antibody (DISC-0974, Research Use)
NBR-0365
Genentech patent anti-TAT226
TAT226
Human TAT226 Antibody (Genentech patent anti-TAT226, Research Use)
NBR-0366
Regeneron patent anti-TMPRSS2 
TMPRSS2
Human TMPRSS2 Antibody (Regeneron patent anti-TMPRSS2 , Research Use)
NBR-0367
Genentech patent anti-HGFA 
HGFA
Human HGFA Antibody (Genentech patent anti-HGFA , Research Use)
NBR-0368
Chugai patent anti-HLA-DQ2
HLA-DQ2
Human HLA-DQ2 Antibody (Chugai patent anti-HLA-DQ2, Research Use)
NBR-0369
Genentech patent anti-KLK5
KLK5
Human KLK5 Antibody (Genentech patent anti-KLK5, Research Use)
NBR-0370
Amgen patent anti-ORAI1
ORAI1
Human ORAI1 Antibody (Amgen patent anti-ORAI1, Research Use)
NBR-0371
Sanofi patent anti-PAI-1
PAI-1
Human PAI-1 Antibody (Sanofi patent anti-PAI-1, Research Use)
NBR-0372
Novartis patent anti-PAR1
PAR1
Human PAR1 Antibody (Novartis patent anti-PAR1, Research Use)
NBR-0373
U.Penn. patent anti-PF4
PF4 / CXCL4
Human PF4 / CXCL4 Antibody (U.Penn. patent anti-PF4, Research Use)
NBR-0374
Multiple seq-one in animal
PROKR1
Human PROKR1 Antibody (Multiple seq-one in animal, Research Use)
NBR-0375
Numab patent anti-HSA
Serum Albumin
Human Serum Albumin Antibody (Numab patent anti-HSA, Research Use)
NBR-0376
Genentech patent anti-STOP-1
STOP-1
Human STOP-1 Antibody (Genentech patent anti-STOP-1, Research Use)
NBR-0377
Janssen patent anti-TMEFF2
TENB2
Human TENB2 Antibody (Janssen patent anti-TMEFF2, Research Use)
NBR-0378
Regeneron patent anti-TIE-2
TIE-2
Human TIE-2 Antibody (Regeneron patent anti-TIE-2, Research Use)
NBR-0379
Novartis patent anti-TMEM16A 
TMEM16A
Human TMEM16A Antibody (Novartis patent anti-TMEM16A , Research Use)
NBR-0380
Genentech patent anti-Polyubiquitin
Polyubiquitin
Human Polyubiquitin Antibody (Genentech patent anti-Polyubiquitin, Research Use)
NBR-0381
Duke anti-NAv1.7
Nav1.7
Human Nav1.7 Antibody (Duke anti-NAv1.7, Research Use)
NBR-0382
Genentech patent anti-Integrin  β7
Integrin B7
Human Integrin B7 Antibody (Genentech patent anti-Integrin  β7, Research Use)
NBR-0383
Genentech patent anti-Jagged1
JAG1
Human JAG1 Antibody (Genentech patent anti-Jagged1, Research Use)
NBR-0384
Regeneron patent anti-APLNR
APLNR
Human APLNR Antibody (Regeneron patent anti-APLNR, Research Use)
NBR-0385
Immunomedics patent anti-Histone H2B
Histone H2B
Human Histone H2B Antibody (Immunomedics patent anti-Histone H2B, Research Use)
NBR-0386
Immunomedics patent anti-Histone H3
Histone H3
Human Histone H3 Antibody (Immunomedics patent anti-Histone H3, Research Use)
NBR-0387
Immunomedics patent anti-Histone H4
Histone H4
Human Histone H4 Antibody (Immunomedics patent anti-Histone H4, Research Use)
NBR-0388
19G9
RG1
Human RG1 Antibody (19G9, Research Use)
NBR-0389
Regeneron patent anti-ANGPTL8
ANGPTL8
Human ANGPTL8 Antibody (Regeneron patent anti-ANGPTL8, Research Use)
NBR-0390
Lilly patent anti-Pan-ELR+
CXC-ELR
Human CXC-ELR Antibody (Lilly patent anti-Pan-ELR+, Research Use)
NBR-0391
FHTR2163
HtrA1
Human HtrA1 Antibody (FHTR2163, Research Use)
NBR-0392
Bayer patent anti-TIMP-1
TIMP1
Human TIMP1 Antibody (Bayer patent anti-TIMP-1, Research Use)
NBR-0393
PF-06263507
TPBG
Human TPBG Antibody (PF-06263507, Research Use)
NBR-0394
OR2805
CD163
Human CD163 Antibody (OR2805, Research Use)
NBR-0395
Canakinumab
IL-1B
Human IL-1B Antibody (Canakinumab, Research Use)
NBR-0396
Lulizumab
CD28
Human CD28 Antibody (Lulizumab, Research Use)
NBR-0397
RG7841
Ly6E
Human Ly6E Antibody (RG7841, Research Use)
NBR-0398
CRX-014
TIM-1
Human TIM-1 Antibody (CRX-014, Research Use)
NBR-0399
OBI-833
Globo H
Human Globo H Antibody (OBI-833, Research Use)
NBR-0400
ADCT-901
KAAG1
Human KAAG1 Antibody (ADCT-901, Research Use)
NBR-0401
KHK2898
CD98
Human CD98 Antibody (KHK2898, Research Use)
NBR-0402
ATN-658
uPAR
Human uPAR Antibody (ATN-658, Research Use)
NBR-0403
LIV-1205
DLK-1
Human DLK-1 Antibody (LIV-1205, Research Use)
NBR-0404
Ontuxizumab
Endosialin
Human Endosialin Antibody (Ontuxizumab, Research Use)
NBR-0405
Midwestern U. patent anti-ASPH
HAAH
Human HAAH Antibody (Midwestern U. patent anti-ASPH, Research Use)
NBR-0406
Oxford Bio patent anti-Matriptase
Matriptase
Human Matriptase Antibody (Oxford Bio patent anti-Matriptase, Research Use)
NBR-0407
Copenhagen Rigshospitalet patent anti-uPARAP
MRC2
Human MRC2 Antibody (Copenhagen Rigshospitalet patent anti-uPARAP, Research Use)
NBR-0408
AG02-ADC
PTGFRN
Human PTGFRN Antibody (AG02-ADC, Research Use)
NBR-0409
Agensys patent anti-158P1D7
158P1D7
Human 158P1D7 Antibody (Agensys patent anti-158P1D7, Research Use)
NBR-0410
Centrose patent anti-dysadherin
dysadherin
Human dysadherin Antibody (Centrose patent anti-dysadherin, Research Use)
NBR-0411
Bluefin patent anti-TMEFF1
TMEFF1
Human TMEFF1 Antibody (Bluefin patent anti-TMEFF1, Research Use)
NBR-0412
Regeneron patent anti-RET
c-RET
Human c-RET Antibody (Regeneron patent anti-RET, Research Use)
NBR-0413
Cantuzumab
C242
Human C242 Antibody (Cantuzumab, Research Use)
NBR-0414
Tamrintamab
DPEP3
Human DPEP3 Antibody (Tamrintamab, Research Use)
NBR-0415
Bivatuzumab
CD44v6
Human CD44v6 Antibody (Bivatuzumab, Research Use)
NBR-0416
 abituzumab
Integrin AV
Human Integrin AV Antibody ( abituzumab, Research Use)
NBR-0417
Minomic patent anti-Glypican 1
Glypican 1
Human Glypican 1 Antibody (Minomic patent anti-Glypican 1, Research Use)
NBR-0418
Scripps patent anti-CD11a
Integrin A11
Human Integrin A11 Antibody (Scripps patent anti-CD11a, Research Use)
NBR-0419
GlycoNex patent anti-Lewis Y / B 
Lewis Y / B antigen
Human Lewis Y / B antigen Antibody (GlycoNex patent anti-Lewis Y / B , Research Use)
NBR-0420
Metuzumab
BSG2
Human BSG2 Antibody (Metuzumab, Research Use)
NBR-0421
F16-IL2
Tenascin C
Human Tenascin C Antibody (F16-IL2, Research Use)
NBR-0422
INSERM patent anti-Glycophorin A
Glycophorin A
Human Glycophorin A Antibody (INSERM patent anti-Glycophorin A, Research Use)
NBR-0423
Ecromeximab
GD3
Human GD3 Antibody (Ecromeximab, Research Use)
NBR-0424
 PF-03732010
P-cadherin
Human P-cadherin Antibody ( PF-03732010, Research Use)
NBR-0425
Rolinsatamab
PRLR
Human PRLR Antibody (Rolinsatamab, Research Use)
NBR-0426
Cevostamab
IRTA2
Human IRTA2 Antibody (Cevostamab, Research Use)
NBR-0427
DEDN6526A
ETB-R
Human ETB-R Antibody (DEDN6526A, Research Use)
NBR-0428
Samrotamab
LFL2
Human LFL2 Antibody (Samrotamab, Research Use)
NBR-0429
ASG-5ME
SLC44A4
Human SLC44A4 Antibody (ASG-5ME, Research Use)
NBR-0430
Sirtratumab
SLITRK6
Human SLITRK6 Antibody (Sirtratumab, Research Use)
NBR-0431
 SAR428926
LAMP1
Human LAMP1 Antibody ( SAR428926, Research Use)
NBR-0432
PF-06647263
EFNA4
Human EFNA4 Antibody (PF-06647263, Research Use)
NBR-0433
Cusatuzumab
CD27L / CD70
Human CD27L / CD70 Antibody (Cusatuzumab, Research Use)
NBR-0434
CDX-0158
c-Kit
Human c-Kit Antibody (CDX-0158, Research Use)
NBR-0435
Tarextumab
Notch3
Human Notch3 Antibody (Tarextumab, Research Use)
NBR-0436
SGN-CD352A
SLAMF6
Human SLAMF6 Antibody (SGN-CD352A, Research Use)
NBR-0437
Lupartumab
C4.4a
Human C4.4a Antibody (Lupartumab, Research Use)
NBR-0438
IMMU-114
HLA-DR
Human HLA-DR Antibody (IMMU-114, Research Use)
NBR-0439
Blinatumomab
CD3
Human CD3 Antibody (Blinatumomab, Research Use)
NBR-0440
Secukinumab
IL-17
Human IL-17 Antibody (Secukinumab, Research Use)
NBR-0441
Tralokinumab
IL-13
Human IL-13 Antibody (Tralokinumab, Research Use)
NBR-0442
Zanolimumab
CD4
Human CD4 Antibody (Zanolimumab, Research Use)
NBR-0443
Forerunner patent anti-DSG3
DSG3
Human DSG3 Antibody (Forerunner patent anti-DSG3, Research Use)
NBR-0444
 AFM13
FCgR3A
Human FCgR3A Antibody ( AFM13, Research Use)
NBR-0445
JNJ-69086420
KLK2
Human KLK2 Antibody (JNJ-69086420, Research Use)
NBR-0446
K1-70
TSHR
Human TSHR Antibody (K1-70, Research Use)
NBR-0447
Mellitus patent anti-CD59
CD59
Human CD59 Antibody (Mellitus patent anti-CD59, Research Use)
NBR-0448
Zymogenetics patent anti-BCMA / TACI
BCMA & TACI
Human BCMA & TACI Antibody (Zymogenetics patent anti-BCMA / TACI, Research Use)
NBR-0449
Teplizumab
CD3e
Human CD3e Antibody (Teplizumab, Research Use)
NBR-0450
Argenx patent anti-MuSK
MUSK
Human MUSK Antibody (Argenx patent anti-MuSK, Research Use)
NBR-0451
CLN-619
MICA
Human MICA Antibody (CLN-619, Research Use)
NBR-0452
CDH17_A4
CDH17
Human CDH17 Antibody (CDH17_A4, Research Use)
NBR-0453
Eculizumab
C5
Human C5 Antibody (Eculizumab, Research Use)
NBR-0454
PAR650097
PAR-2
Human PAR-2 Antibody (PAR650097, Research Use)
NBR-0455
Nadecnemab
GFRA3
Human GFRA3 Antibody (Nadecnemab, Research Use)
NBR-0456
Atrosimab
TNFRSF1A
Human TNFRSF1A Antibody (Atrosimab, Research Use)
NBR-0457
PY159
TREM-1
Human TREM-1 Antibody (PY159, Research Use)
NBR-0458
RG6125
Cadherin-11
Human Cadherin-11 Antibody (RG6125, Research Use)
NBR-0459
Wuhan U. patent anti-Nav1.9
Nav1.9
Human Nav1.9 Antibody (Wuhan U. patent anti-Nav1.9, Research Use)
NBR-0460
U.Tokyo patent anti-TLR7
TLR7
Human TLR7 Antibody (U.Tokyo patent anti-TLR7, Research Use)
NBR-0461
Leronlimab
CCR5
Human CCR5 Antibody (Leronlimab, Research Use)
NBR-0462
Drozitumab
DR5 / TRAILR2
Human DR5 / TRAILR2 Antibody (Drozitumab, Research Use)
NBR-0463
MEN1309
LY75
Human LY75 / CD205 Antibody (MEN1309, Research Use)
NBR-0464
Adalimumab
TNFSF2
Human TNFSF2 / TNFa Antibody (Adalimumab, Research Use)
NBR-0465
HKT288
CDH6
Human CDH6 / K-Cadherin Antibody (HKT288, Research Use)
NBR-0466
Genefrontier patent anti-CD69
CD69
Human CD69 Antibody (Genefrontier patent anti-CD69, Research Use)
NBR-0467
Scripps Korea patent anti-CLEC14A
CLEC14A
Human CLEC14A Antibody (Scripps Korea patent anti-CLEC14A, Research Use)
NBR-0468
Oxford Bio patent anti-CRTAM
CRTAM
Human CRTAM / CD355 Antibody (Oxford Bio patent anti-CRTAM, Research Use)
NBR-0469
Med. Bio. Labs patent anti-CXADR
CXADR
Human CXADR Antibody (Med. Bio. Labs patent anti-CXADR, Research Use)
NBR-0470
Novimmune patent anti-CXCL9
CXCL9
Human CXCL9 Antibody (Novimmune patent anti-CXCL9, Research Use)
NBR-0471
INSERM patent anti-DC-SIGN
CD209
Human DC-SIGN / CD209 Antibody (INSERM patent anti-DC-SIGN, Research Use)
NBR-0472
Amgen patent anti-Ferroportin
SLC40A1
Human SLC40A1 Antibody (Amgen patent anti-Ferroportin, Research Use)
NBR-0473
CSL patent anti-G-CSFR
CSF3R
Human CSF3R / G-CSFR Antibody (CSL patent anti-G-CSFR, Research Use)
NBR-0474
KHK patent anti-Haptoglobin
Haptoglobin
Human Haptoglobin Antibody (KHK patent anti-Haptoglobin, Research Use)
NBR-0475
Wake Forest U. patent anti-IL-13RA2
IL-13Ra2
Human IL-13Ra2 / CD213a2 Antibody (Wake Forest U. patent anti-IL-13RA2, Research Use)
NBR-0476
Cheng Kung U. patent anti-IL-20R1
IL20RA
Human IL-20Ra Antibody (Cheng Kung U. patent anti-IL-20R1, Research Use)
NBR-0477
Enokizumab
IL-9
Human IL-9 Antibody (Enokizumab, Research Use)
NBR-0478
Innate patent anti-KIR2DL
KIR2DL1
Human KIR2DL1 / CD158a Antibody (Innate patent anti-KIR2DL, Research Use)
NBR-0479
Novo Nordisk patent anti-PGLYRP1
PGLYRP1
Human PGLYRP1 / PGRP-S Antibody (Novo Nordisk patent anti-PGLYRP1, Research Use)
NBR-0480
Diaccurate patent anti-sPLA2-GIB
PLA2G1B
Human PLA2G1B Antibody (Diaccurate patent anti-sPLA2-GIB, Research Use)
NBR-0481
Oncomed patent anti-RSPO1
RSPO1
Human RSPO1 Antibody (Oncomed patent anti-RSPO1, Research Use)
NBR-0482
Mapatumumab
TNFRSF10A
Human TNFRSF10A / TRAILR1 / CD261 Antibody (Mapatumumab, Research Use)
NBR-0483
Regeneron patent anti-CD48
CD48
Human CD48 Antibody (Regeneron patent anti-CD48, Research Use)
NBR-0484
Regeneron patent anti-PROKR1
PROKR1
Human GPR73 / PROKR1 Antibody (Regeneron patent anti-PROKR1, Research Use)
NBR-0485
Genentech patent anti-Polyubiquitin
UBB
Human Polyubiquitin Antibody (Genentech patent anti-Polyubiquitin, Research Use)
NBR-0486
SAR428926
LAMP1
Human LAMP1 / CD107a Antibody (SAR428926, Research Use)
NBR-0487
Forerunner patent anti-DSG3
DSG3
Human DSG3 Antibody (Forerunner patent anti-DSG3, Research Use)
NBR-0488
AFM13
FcgR3a
Human FcgR3a / CD16a Antibody (AFM13, Research Use)
NBR-0489
Mellitus patent anti-CD59
CD59
Human CD59 Antibody (Mellitus patent anti-CD59, Research Use)
NBR-0490
Selicrelumab
CD40
Human TNFRSF5 / CD40 Antibody (Selicrelumab, Research Use)
NBR-0491
Domagrozumab
GDF8
Human GDF8 / Myostatin Antibody (Domagrozumab, Research Use)
NBR-0492
Abrilumab
 ITGA4 & ITGB7
Human Integrin a4b7 (ITGA4 & ITGB7) Antibody (Abrilumab, Research Use)
NBR-0493
Amlitelimab
TNFSF4
Human TNFSF4 / OX40L / CD252 Antibody (Amlitelimab, Research Use)
NBR-0494
Abagovomab
MUC16
Human MUC16 Antibody (Abagovomab, Research Use)
NBR-0495
Birtamimab
 SAA1
Human Amyloid Alpha Antibody (Birtamimab, Research Use)
NBR-0496
Aducanumab
 APP
Human Amyloid Beta Antibody (Aducanumab, Research Use)
NBR-0497
Abbott patent anti-Flt1
VEGFR1
Human VEGFR1 / FLT1 Antibody (Abbott patent anti-Flt1, Research Use)
NBR-0498
Crenezumab
 APP
Human Amyloid Beta Antibody (Crenezumab, Research Use)
NBR-0499
DLX212
 APP
Human Amyloid Beta Antibody (DLX212, Research Use)
NBR-0500
Acceleron patent anti-ActRIIB
ACVR2B
Human ACVR2B Antibody (Acceleron patent anti-ActRIIB, Research Use)
NBR-0501
Gantenerumab
 APP
Human Amyloid Beta Antibody (Gantenerumab, Research Use)
NBR-0502
Actoxumab
N/A
Human Cdiff Toxin A Antibody (Actoxumab, Research Use)
NBR-0503
GSK 933776
 APP
Human Amyloid Beta Antibody (GSK 933776, Research Use)
NBR-0504
Ajinomoto patent anti-vWF
vWF
Human vWF Antibody (Ajinomoto patent anti-vWF, Research Use)
NBR-0505
Alomfilimab
ICOS
Human ICOS / CD278 Antibody (Alomfilimab, Research Use)
NBR-0506
Amgen patent anti-beta amyloid
 APP
Human Amyloid Beta Antibody (Amgen patent anti-beta amyloid, Research Use)
NBR-0507
MEDI3617
ANGPT2
Human ANGPT2 Antibody (MEDI3617, Research Use)
NBR-0508
Apitegromab
GDF8
Human GDF8 / Myostatin Antibody (Apitegromab, Research Use)
NBR-0509
Zansecimab
ANGPT2
Human ANGPT2 Antibody (Zansecimab, Research Use)
NBR-0510
Nanyang Tech.U. patent anti-ANGPTL4
ANGPTL4
Human ANGPTL4 Antibody (Nanyang Tech.U. patent anti-ANGPTL4, Research Use)
NBR-0511
Astegolimab
IL-1RL1
Human IL-1RL1 / ST2 / IL-33R Antibody (Astegolimab, Research Use)
NBR-0512
Avdoralimab
 C5AR1
Human Complement C5aR1 Antibody (Avdoralimab, Research Use)
NBR-0513
Aveo anti-RON
MST1R
Human MSPR / RON / CD136 Antibody (Aveo anti-RON, Research Use)
NBR-0514
MipasetamAb
AXL
Human AXL / UFO Antibody (MipasetamAb, Research Use)
NBR-0515
Adebrelimab
CD274
Human B7-H1 / PD-L1 / CD274 Antibody (Adebrelimab, Research Use)
NBR-0516
Batoclimab
FCGRT
Human FcRn (FCGRT & B2M) Antibody (Batoclimab, Research Use)
NBR-0517
Baylor patent anti-IFN alpha
IFNa1
Human IFNa1 Antibody (Baylor patent anti-IFN alpha, Research Use)
NBR-0518
Garivulimab
 CD274
Human B7-H1 / PD-L1 / CD274 Antibody (Garivulimab, Research Use)
NBR-0519
Befovacimab
 TFPI
Human TFPI Antibody (Befovacimab, Research Use)
NBR-0520
Manelimab
 CD274
Human B7-H1 / PD-L1 / CD274 Antibody (Manelimab, Research Use)
NBR-0521
Begelomab
DPP4
Human DPP4 / CD26 Antibody (Begelomab, Research Use)
NBR-0522
Pacmilimab
 CD274
Human B7-H1 / PD-L1 / CD274 Antibody (Pacmilimab, Research Use)
NBR-0523
Sudubrilimab
 CD274
Human B7-H1 / PD-L1 / CD274 Antibody (Sudubrilimab, Research Use)
NBR-0524
Sugemalimab
 CD274
Human B7-H1 / PD-L1 / CD274 Antibody (Sugemalimab, Research Use)
NBR-0525
Prezalumab
ICOSLG
Human B7-H2 / ICOSL / CD275 Antibody (Prezalumab, Research Use)
NBR-0526
Trellis patent anti-B7-H3
CD276
Human B7-H3 / CD276 Antibody (Trellis patent anti-B7-H3, Research Use)
NBR-0527
Millennium patent anti-B7-H4
 VTCN1
Human B7-H4 / VTCN1 Antibody (Millennium patent anti-B7-H4, Research Use)
NBR-0528
Genentech anti-BACE1
BACE1
Human BACE1 Antibody (Genentech anti-BACE1, Research Use)
NBR-0529
Blosozumab
 SOST
Human SOST / Sclerostin Antibody (Blosozumab, Research Use)
NBR-0530
Bococizumab
PCSK9
Human PCSK9 Antibody (Bococizumab, Research Use)
NBR-0531
Boehringer anti-PCSK9
PCSK9
Human PCSK9 Antibody (Boehringer anti-PCSK9, Research Use)
NBR-0532
Eptinezumab
 CALCA
Human CALCA / CGRP Antibody (Eptinezumab, Research Use)
NBR-0533
Fremanezumab
 CALCA
Human CALCA / CGRP Antibody (Fremanezumab, Research Use)
NBR-0534
Galcanezumab
 CALCA
Human CALCA / CGRP Antibody (Galcanezumab, Research Use)
NBR-0535
Brigham and Women's patent anti-ABCB5
 ABCB5
Human ABCB5 Antibody (Brigham and Women's patent anti-ABCB5, Research Use)
NBR-0536
Nimacimab
CNR1
Human CB1 / CNR1 Antibody (Nimacimab, Research Use)
NBR-0537
Carlumab
CCL2
Human CCL2 / MCP1 Antibody (Carlumab, Research Use)
NBR-0538
NI-0701
 CCL5
Human CCL5 / RANTES Antibody (NI-0701, Research Use)
NBR-0539
Pierre Fabre patent anti-CD151
CD151
Human CD151 Antibody (Pierre Fabre patent anti-CD151, Research Use)
NBR-0540
Centocor patent anti-CD147
BSG
Human EMMPRIN / CD147 Antibody (Centocor patent anti-CD147, Research Use)
NBR-0541
Denintuzumab
CD19
Human CD19 Antibody (Denintuzumab, Research Use)
NBR-0542
Duke U. patent anti-CD19
CD19
Human CD19 Antibody (Duke U. patent anti-CD19, Research Use)
NBR-0543
Centocor patent anti-IL-25
IL25
Human IL-25 Antibody (Centocor patent anti-IL-25, Research Use)
NBR-0544
CertolizumAb
TNFSF2
Human TNFSF2 / TNFa Antibody (CertolizumAb, Research Use)
NBR-0545
Siplizumab
CD2
Human CD2 Antibody (Siplizumab, Research Use)
NBR-0546
Chinese CDC patent anti-Interferon Alpha
IFNA1
Human IFNa1 Antibody (Chinese CDC patent anti-Interferon Alpha, Research Use)
NBR-0547
CNTO 2125
 APP
Human Amyloid Beta Antibody (CNTO 2125, Research Use)
NBR-0548
CNTO 607
 IL13
Human IL-13 Antibody (CNTO 607, Research Use)
NBR-0549
CNTO5429
TLR3
Human TLR3 / CD283 Antibody (CNTO5429, Research Use)
NBR-0550
Cobolimab
 HAVCR2
Human TIM-3 / HAVCR2 / CD366 Antibody (Cobolimab, Research Use)
NBR-0551
Cofetuzumab
PTK7
Human PTK7 / CCK4 Antibody (Cofetuzumab, Research Use)
NBR-0552
Coltuximab
 CD19
Human CD19 Antibody (Coltuximab, Research Use)
NBR-0553
Concizumab
 TFPI
Human TFPI Antibody (Concizumab, Research Use)
NBR-0554
Ripertamab
CD20
Human CD20 Antibody (Ripertamab, Research Use)
NBR-0555
TRU-015
CD20
Human CD20 Antibody (TRU-015, Research Use)
NBR-0556
Ublituximab
CD20
Human CD20 Antibody (Ublituximab, Research Use)
NBR-0557
Veltuzumab
CD20
Human CD20 Antibody (Veltuzumab, Research Use)
NBR-0558
Zuberitamab
CD20
Human CD20 Antibody (Zuberitamab, Research Use)
NBR-0559
FR104
CD28
Human CD28 Antibody (FR104, Research Use)
NBR-0560
Galiximab
CD80
Human CD28L / CD80 Antibody (Galiximab, Research Use)
NBR-0561
Coprelotamab
ERBB2
Human ERBB2 / HER2 / CD340 Antibody (Coprelotamab, Research Use)
NBR-0562
Cosibelimab
 CD274
Human B7-H1 / PD-L1 / CD274 Antibody (Cosibelimab, Research Use)
NBR-0563
Crovalimab
C5
Human Complement C5 Antibody (Crovalimab, Research Use)
NBR-0564
CSIRO anti-amyloid Beta scFv
 APP
Human Amyloid Beta Antibody (CSIRO anti-amyloid Beta scFv, Research Use)
NBR-0565
Cudarolimab
TNFRSF4
Human TNFRSF4 / OX40 / CD134 Antibody (Cudarolimab, Research Use)
NBR-0566
Dalotuzumab
IGF1R
Human IGF1R / CD221 Antibody (Dalotuzumab, Research Use)
NBR-0567
Dapirolizumab
CD40LG
Human TNFSF5 / CD40L / CD154 Antibody (Dapirolizumab, Research Use)
NBR-0568
Visilizumab
 CD3E
Human CD3 Antibody (Visilizumab, Research Use)
NBR-0569
ITRI patent anti-CD34
CD34
Human CD34 Antibody (ITRI patent anti-CD34, Research Use)
NBR-0570
Felzartamab
CD38
Human CD38 Antibody (Felzartamab, Research Use)
NBR-0571
Isatuximab
CD38
Human CD38 Antibody (Isatuximab, Research Use)
NBR-0572
Mezagitamab
CD38
Human CD38 Antibody (Mezagitamab, Research Use)
NBR-0573
Ibalizumab
CD4
Human CD4 Antibody (Ibalizumab, Research Use)
NBR-0574
Tregalizumab
CD4
Human CD4 Antibody (Tregalizumab, Research Use)
NBR-0575
TRX1
CD4
Human CD4 Antibody (TRX1, Research Use)
NBR-0576
Depemokimab
IL-5
Human IL-5 Antibody (Depemokimab, Research Use)
NBR-0577
Derlotuximab
H1-0
Human Histone H1 Antibody (Derlotuximab, Research Use)
NBR-0578
Divozilimab
CD20
Human CD20 Antibody (Divozilimab, Research Use)
NBR-0579
Letaplimab
CD47
Human CD47 Antibody (Letaplimab, Research Use)
NBR-0580
Ligufalimab
CD47
Human CD47 Antibody (Ligufalimab, Research Use)
NBR-0581
LintuzumAb
CD33
Human Siglec-3 / CD33 Antibody (LintuzumAb, Research Use)
NBR-0582
Urabrelimab
CD47
Human CD47 Antibody (Urabrelimab, Research Use)
NBR-0583
Domantis patent anti-VEGF
VEGF
Human VEGF Antibody (Domantis patent anti-VEGF, Research Use)
NBR-0584
Dompe patent anti-FOLR1
FOLR1
Human FOLR1 Antibody (Dompe patent anti-FOLR1, Research Use)
NBR-0585
Gatralimab
CD52
Human CD52 Antibody (Gatralimab, Research Use)
NBR-0586
Quark patent anti-CD59
CD59
Human CD59 Antibody (Quark patent anti-CD59, Research Use)
NBR-0587
Domvanalimab
TIGIT
Human TIGIT Antibody (Domvanalimab, Research Use)
NBR-0588
Donanemab
Amyloid Beta
Human Amyloid Beta Antibody (Donanemab, Research Use)
NBR-0589
GrisnilimAb
CD7
Human CD7 Antibody (GrisnilimAb, Research Use)
NBR-0590
Dostarlimab
CD279
Human PDCD1 / PD-1 / CD279 Antibody (Dostarlimab, Research Use)
NBR-0591
IladatuzumAb
CD79b
Human CD79b Antibody (IladatuzumAb, Research Use)
NBR-0592
Genentech patent anti-CD83
CD83
Human CD83 Antibody (Genentech patent anti-CD83, Research Use)
NBR-0593
Genentech patent anti-CD9
CD9
Human CD9 Antibody (Genentech patent anti-CD9, Research Use)
NBR-0594
Stem Centrx patent anti-Cadherin-1
CD324
Human CDH1 / E-cadherin / CD324 Antibody (Stem Centrx patent anti-Cadherin-1, Research Use)
NBR-0595
PF-03732010
CDH3
Human CDH3 / P-cadherin Antibody (PF-03732010, Research Use)
NBR-0596
Chaim Sheba Med. Cntr. patent anti-CEACAM1
CD66a
Human CEACAM1 / CD66a Antibody (Chaim Sheba Med. Cntr. patent anti-CEACAM1, Research Use)
NBR-0597
CergutuzumAb
CD66e
Human CEACAM5 / CEA / CD66e Antibody (CergutuzumAb, Research Use)
NBR-0598
Ebdarokimab
IL-12b
Human IL-12b Antibody (Ebdarokimab, Research Use)
NBR-0599
Tusamitamab
CD66e
Human CEACAM5 / CEA / CD66e Antibody (Tusamitamab, Research Use)
NBR-0600
Ebronucimab
PCSK9
Human PCSK9 Antibody (Ebronucimab, Research Use)
NBR-0601
Tinurilimab
CD66c
Human CEACAM6 / CD66c Antibody (Tinurilimab, Research Use)
NBR-0602
Academia Sinica patent anti-Clathrin Heavy Chain
CHC
Human Clathrin Heavy Chain / CHC Antibody (Academia Sinica patent anti-Clathrin Heavy Chain, Research Use)
NBR-0603
Elsilimomab
IL-6
Human IL-6 / IFNb2 Antibody (Elsilimomab, Research Use)
NBR-0604
Emory U. anti-CD40
CD40
Human TNFRSF5 / CD40 Antibody (Emory U. anti-CD40, Research Use)
NBR-0605
BIIB059
CLEC4C
Human CLEC4C Antibody (BIIB059, Research Use)
NBR-0606
Lendalizumab
Complement C5
Human Complement C5 Antibody (Lendalizumab, Research Use)
NBR-0607
Ravulizumab
Complement C5
Human Complement C5 Antibody (Ravulizumab, Research Use)
NBR-0608
Enoticumab
DLL4
Human DLL4 Antibody (Enoticumab, Research Use)
NBR-0609
G2 patent anti-C5aR
Complement C5aR1
Human Complement C5aR1 Antibody (G2 patent anti-C5aR, Research Use)
NBR-0610
Lampalizumab
Complement Factor D
Human Complement Factor D Antibody (Lampalizumab, Research Use)
NBR-0611
Epitomics patent anti-TNFα
TNFSF2
Human TNFSF2 / TNFa Antibody (Epitomics patent anti-TNFα, Research Use)
NBR-0612
Emactuzumab
CSF1R
Human CSF1R / M-CSFR / CD115 Antibody (Emactuzumab, Research Use)
NBR-0613
LY3022855
CSF1R
Human CSF1R / M-CSFR / CD115 Antibody (LY3022855, Research Use)
NBR-0614
Gimsilumab
CSF2
Human CSF2 / GM-CSF Antibody (Gimsilumab, Research Use)
NBR-0615
Lenzilumab
CSF2
Human CSF2 / GM-CSF Antibody (Lenzilumab, Research Use)
NBR-0616
Namilumab
CSF2
Human CSF2 / GM-CSF Antibody (Namilumab, Research Use)
NBR-0617
Etrolizumab
 ITGA4 & ITGB7
Human Integrin a4b7 (ITGA4 & ITGB7) Antibody (Etrolizumab, Research Use)
NBR-0618
Evolocumab
PCSK9
Human PCSK9 Antibody (Evolocumab, Research Use)
NBR-0619
Expression DD patent anti-SIP
Sphingosine-1-phosphate
Human Sphingosine-1-phosphate Antibody (Expression DD patent anti-SIP, Research Use)
NBR-0620
Finotonlimab
CD279
Human PDCD1 / PD-1 / CD279 Antibody (Finotonlimab, Research Use)
NBR-0621
Flanvotumab
TRP1
Human TRP1 / TYRP1 Antibody (Flanvotumab, Research Use)
NBR-0622
Nurulimab
CD152
Human CTLA-4 / CD152  Antibody (Nurulimab, Research Use)
NBR-0623
Tremelimumab
CD152
Human CTLA-4 / CD152  Antibody (Tremelimumab, Research Use)
NBR-0624
Zalifrelimab
CD152
Human CTLA-4 / CD152  Antibody (Zalifrelimab, Research Use)
NBR-0625
CAT-2200
CTLA-8
Human CTLA-8 / IL-17a Antibody (CAT-2200, Research Use)
NBR-0626
Ixekizumab
CTLA-8
Human CTLA-8 / IL-17a Antibody (Ixekizumab, Research Use)
NBR-0627
Netakimab
CTLA-8
Human CTLA-8 / IL-17a Antibody (Netakimab, Research Use)
NBR-0628
Perakizumab
CTLA-8
Human CTLA-8 / IL-17a Antibody (Perakizumab, Research Use)
NBR-0629
UCB patent anti-IL-17
CTLA-8
Human CTLA-8 / IL-17a Antibody (UCB patent anti-IL-17, Research Use)
NBR-0630
Vunakizumab
CTLA-8
Human CTLA-8 / IL-17a Antibody (Vunakizumab, Research Use)
NBR-0631
Fontolizumab
IFNg
Human IFNg Antibody (Fontolizumab, Research Use)
NBR-0632
NI-0801
CXCL10
Human CXCL10 / IP-10 Antibody (NI-0801, Research Use)
NBR-0633
Genentech anti-CXCL12
CXCL12
Human CXCL12 / SDF1a Antibody (Genentech anti-CXCL12, Research Use)
NBR-0634
ABX-IL8
CXCL8
Human CXCL8 / IL-8 Antibody (ABX-IL8, Research Use)
NBR-0635
Genentech patent anti-IL-8
CXCL8
Human CXCL8 / IL-8 Antibody (Genentech patent anti-IL-8, Research Use)
NBR-0636
Foralumab
CD3e
Human CD3e Antibody (Foralumab, Research Use)
NBR-0637
Dana-Farber patent anti-CXCR4
 CXCR4
Human CXCR4 / CD184 Antibody (Dana-Farber patent anti-CXCR4, Research Use)
NBR-0638
Forerunner patent anti-ICAM-3
ICAM3
Human ICAM3 / CD50 Antibody (Forerunner patent anti-ICAM-3, Research Use)
NBR-0639
Forerunner patent anti-Muc 17
MUC17
Human MUC17 Antibody (Forerunner patent anti-Muc 17, Research Use)
NBR-0640
Fox Chase patent anti-TEM7R
 PLXDC2
Human TEM7R / PLXDC2 Antibody (Fox Chase patent anti-TEM7R, Research Use)
NBR-0641
Fresolimumab
TGFB1
Human TGFb1 Antibody (Fresolimumab, Research Use)
NBR-0642
Frovocimab
PCSK9
Human PCSK9 Antibody (Frovocimab, Research Use)
NBR-0643
Smart Targeting patent anti-DLL4
 DLL4
Human DLL4 Antibody (Smart Targeting patent anti-DLL4, Research Use)
NBR-0644
Gancotamab
ERBB2
Human ERBB2 / HER2 / CD340 Antibody (Gancotamab, Research Use)
NBR-0645
Gatipotuzumab
 MUC1
Human MUC1 Antibody (Gatipotuzumab, Research Use)
NBR-0646
Parsatuzumab
EGFL7
Human EGFL7 Antibody (Parsatuzumab, Research Use)
NBR-0647
Genentech patent anti-Factor B
CFB
Human Complement Factor B Antibody (Genentech patent anti-Factor B, Research Use)
NBR-0648
Genentech patent anti-Notch3
NOTCH3
Human NOTCH3 Antibody (Genentech patent anti-Notch3, Research Use)
NBR-0649
Adecatumumab
 EPCAM
Human EpCAM / TROP1 / CD326 Antibody (Adecatumumab, Research Use)
NBR-0650
Georgetown U. patent anti-Amyloid Beta
 APP
Human Amyloid Beta Antibody (Georgetown U. patent anti-Amyloid Beta, Research Use)
NBR-0651
Geptanolimab
PDCD1
Human PDCD1 / PD-1 / CD279 Antibody (Geptanolimab, Research Use)
NBR-0652
Gevokizumab
IL-1b
Human IL-1b Antibody (Gevokizumab, Research Use)
NBR-0653
Giloralimab
CD40
Human TNFRSF5 / CD40 Antibody (Giloralimab, Research Use)
NBR-0654
7A7
ERBB1
Human ERBB1 / EGFR / HER1 Antibody (7A7, Research Use)
NBR-0655
Chinese Mil.Med.Sci. patent anti-EGFR
ERBB1
Human ERBB1 / EGFR / HER1 Antibody (Chinese Mil.Med.Sci. patent anti-EGFR, Research Use)
NBR-0656
Demupitamab
ERBB1
Human ERBB1 / EGFR / HER1 Antibody (Demupitamab, Research Use)
NBR-0657
Depatuxizumab
ERBB1
Human ERBB1 / EGFR / HER1 Antibody (Depatuxizumab, Research Use)
NBR-0658
Duke D2C7
ERBB1
Human ERBB1 / EGFR / HER1 Antibody (Duke D2C7, Research Use)
NBR-0659
Imgatuzumab
ERBB1
Human ERBB1 / EGFR / HER1 Antibody (Imgatuzumab, Research Use)
NBR-0660
LaprituximAb
ERBB1
Human ERBB1 / EGFR / HER1 Antibody (LaprituximAb, Research Use)
NBR-0661
Matuzumab
ERBB1
Human ERBB1 / EGFR / HER1 Antibody (Matuzumab, Research Use)
NBR-0662
Necitumumab
ERBB1
Human ERBB1 / EGFR / HER1 Antibody (Necitumumab, Research Use)
NBR-0663
Golimumab
TNFSF2
Human TNFSF2 / TNFa Antibody (Golimumab, Research Use)
NBR-0664
Pimurutamab
ERBB1
Human ERBB1 / EGFR / HER1 Antibody (Pimurutamab, Research Use)
NBR-0665
Shanghai Cancer Inst patent anti-EGFRvIII
ERBB1
Human ERBB1 / EGFR / HER1 Antibody (Shanghai Cancer Inst patent anti-EGFRvIII, Research Use)
NBR-0666
Zalutumumab
ERBB1
Human ERBB1 / EGFR / HER1 Antibody (Zalutumumab, Research Use)
NBR-0667
Ibritumomab
CD20
Human CD20 Antibody (Ibritumomab, Research Use)
NBR-0668
Icatolimab
BTLA
Human BTLA / CD272 Antibody (Icatolimab, Research Use)
NBR-0669
Ifabotuzumab
EphA3
Human EphA3 Antibody (Ifabotuzumab, Research Use)
NBR-0670
Hersintuzumab
ERBB2
Human ERBB2 / HER2 / CD340 Antibody (Hersintuzumab, Research Use)
NBR-0671
Margetuximab
ERBB2
Human ERBB2 / HER2 / CD340 Antibody (Margetuximab, Research Use)
NBR-0672
Timigutuzumab
ERBB2
Human ERBB2 / HER2 / CD340 Antibody (Timigutuzumab, Research Use)
NBR-0673
Barecetamab
ERBB3
Human ERBB3 / HER3 Antibody (Barecetamab, Research Use)
NBR-0674
Lumretuzumab
ERBB3
Human ERBB3 / HER3 Antibody (Lumretuzumab, Research Use)
NBR-0675
Imclone 6.64
KDR
Human VEGFR2 / KDR / CD309 Antibody (Imclone 6.64, Research Use)
NBR-0676
Immunomedics hA19
CD19
Human CD19 Antibody (Immunomedics hA19, Research Use)
NBR-0677
Abelacimab
F11
Human F11 / Factor XI Antibody (Abelacimab, Research Use)
NBR-0678
Lumiliximab
FCER2
Human FceR2 / CD23 Antibody (Lumiliximab, Research Use)
NBR-0679
DFRF4539A
FcRL5
Human FcRL5 / IRTA2 Antibody (DFRF4539A, Research Use)
NBR-0680
Immunomedics patent anti-IGF-1R
IGF1R
Human IGF1R / CD221 Antibody (Immunomedics patent anti-IGF-1R, Research Use)
NBR-0681
Imperial College anti-DDR1
DDR1
Human DDR1 / CD167a Antibody (Imperial College anti-DDR1, Research Use)
NBR-0682
Lilly patent anti-FGFR-1
FGFR1
Human FGFR1 / CD331 Antibody (Lilly patent anti-FGFR-1, Research Use)
NBR-0683
INSERM patent anti-CO-029
TSPAN8
Human TSPAN8 Antibody (INSERM patent anti-CO-029, Research Use)
NBR-0684
Radretumab
FN1
Human Fibronectin Antibody (Radretumab, Research Use)
NBR-0685
PelgifatamAb
FOLH1 
Human FOLH1 / PSMA Antibody (PelgifatamAb, Research Use)
NBR-0686
Iparomlimab
PDCD1
Human PDCD1 / PD-1 / CD279 Antibody (Iparomlimab, Research Use)
NBR-0687
Vantictumab
FZD
Human FZD Antibody (Vantictumab, Research Use)
NBR-0688
Ivuxolimab
TNFRSF4
Human TNFRSF4 / OX40 / CD134 Antibody (Ivuxolimab, Research Use)
NBR-0689
Jackson Foundation patent anti-ERG
ERG
Human ERG Antibody (Jackson Foundation patent anti-ERG, Research Use)
NBR-0690
Dinutuximab
N/A
Human GD2 Antibody (Dinutuximab, Research Use)
NBR-0691
EMD 273063
N/A
Human GD2 Antibody (EMD 273063, Research Use)
NBR-0692
Korea Natl.Cancer Ctr. patent anti-GITR
TNFRSF18
Human TNFRSF18 / GITR / CD357 Antibody (Korea Natl.Cancer Ctr. patent anti-GITR, Research Use)
NBR-0693
Korea RIBB patent anti-cMet
MET
Human HGFR / c-Met Antibody (Korea RIBB patent anti-cMet, Research Use)
NBR-0694
Kumamoto U. patent anti-Amyloid Beta
 APP
Human Amyloid Beta Antibody (Kumamoto U. patent anti-Amyloid Beta, Research Use)
NBR-0695
Latozinemab
SORT1
Human Sortilin / SORT1 Antibody (Latozinemab, Research Use)
NBR-0696
Lemzoparlimab
CD47
Human CD47 Antibody (Lemzoparlimab, Research Use)
NBR-0697
Lilotomab
CD37
Human TSPAN26 / CD37 Antibody (Lilotomab, Research Use)
NBR-0698
Lodapolimab
 CD274
Human B7-H1 / PD-L1 / CD274 Antibody (Lodapolimab, Research Use)
NBR-0699
Lodelcizumab
PCSK9
Human PCSK9 Antibody (Lodelcizumab, Research Use)
NBR-0700
Facet patent anti-GPR64
ADGRG2
Human GPR64 / ADGRG2 Antibody (Facet patent anti-GPR64, Research Use)
NBR-0701
LonigutamAb
IGF1R
Human IGF1R / CD221 Antibody (LonigutamAb, Research Use)
NBR-0702
LosatuxizumAb
ERBB1
Human ERBB1 / EGFR / HER1 Antibody (LosatuxizumAb, Research Use)
NBR-0703
Ludwig-Maximilians U. anti_Hepsin
HAMP 
Human Hepcidin / HAMP Antibody (Ludwig-Maximilians U. anti_Hepsin, Research Use)
NBR-0704
LY2787106
HAMP 
Human Hepcidin / HAMP Antibody (LY2787106, Research Use)
NBR-0705
Macrogenics patent anti-KID3
KID3
Human KID3 Antibody (Macrogenics patent anti-KID3, Research Use)
NBR-0706
TAK-701
HGF
Human HGF / SF Antibody (TAK-701, Research Use)
NBR-0707
Metheresis patent anti-Met
MET
Human HGFR / c-Met Antibody (Metheresis patent anti-Met, Research Use)
NBR-0708
SAIT301
MET
Human HGFR / c-Met Antibody (SAIT301, Research Use)
NBR-0709
Merck anti-Amyloid beta 19.3
 APP
Human Amyloid Beta Antibody (Merck anti-Amyloid beta 19.3, Research Use)
NBR-0710
Merck patent anti-Amyloid Beta
 APP
Human Amyloid Beta Antibody (Merck patent anti-Amyloid Beta, Research Use)
NBR-0711
MirzotamAb
CD276
Human B7-H3 / CD276 Antibody (MirzotamAb, Research Use)
NBR-0712
Modotuximab
ERBB1
Human ERBB1 / EGFR / HER1 Antibody (Modotuximab, Research Use)
NBR-0713
Bersanlimab
ICAM1
Human ICAM1 / CD54 Antibody (Bersanlimab, Research Use)
NBR-0714
MEDI-570
ICOS
Human ICOS / CD278 Antibody (MEDI-570, Research Use)
NBR-0715
AMG 811
IFNg
Human IFNg Antibody (AMG 811, Research Use)
NBR-0716
Emapalumab
IFNg
Human IFNg Antibody (Emapalumab, Research Use)
NBR-0717
Quilizumab
IGHE
Human IgE (M1 prime) Antibody (Quilizumab, Research Use)
NBR-0718
Ligelizumab
IGHE
Human IgE Antibody (Ligelizumab, Research Use)
NBR-0719
Mupadolimab
NT5E
Human NT5E / CD73 Antibody (Mupadolimab, Research Use)
NBR-0720
Talizumab
IGHE
Human IgE Antibody (Talizumab, Research Use)
NBR-0721
NaptumomAb
TPBG
Human TPBG Antibody (NaptumomAb, Research Use)
NBR-0722
Figitumumab
IGF1R
Human IGF1R / CD221 Antibody (Figitumumab, Research Use)
NBR-0723
Ganitumab
IGF1R
Human IGF1R / CD221 Antibody (Ganitumab, Research Use)
NBR-0724
NIH patent anti-Mesothelin
MSLN
Human Mesothelin Antibody (NIH patent anti-Mesothelin, Research Use)
NBR-0725
Nimotuzumab
ERBB1
Human ERBB1 / EGFR / HER1 Antibody (Nimotuzumab, Research Use)
NBR-0726
DX-2647
IGF2
Human IGF2 Antibody (DX-2647, Research Use)
NBR-0727
BT-063
IL-10
Human IL-10 Antibody (BT-063, Research Use)
NBR-0728
Briakinumab
IL-12a
Human IL-12 (IL-12a & IL-12b) Antibody (Briakinumab, Research Use)
NBR-0729
Nipocalimab
FcRn
Human FcRn (FCGRT & B2M) Antibody (Nipocalimab, Research Use)
NBR-0730
Abrezekimab
IL-13
Human IL-13 Antibody (Abrezekimab, Research Use)
NBR-0731
Cendakimab
IL-13
Human IL-13 Antibody (Cendakimab, Research Use)
NBR-0732
Dectrekumab
IL-13
Human IL-13 Antibody (Dectrekumab, Research Use)
NBR-0733
GSK 679586
IL-13
Human IL-13 Antibody (GSK 679586, Research Use)
NBR-0734
H2L6
IL-13
Human IL-13 Antibody (H2L6, Research Use)
NBR-0735
IMA-026
IL-13
Human IL-13 Antibody (IMA-026, Research Use)
NBR-0736
Lebrikizumab
IL-13
Human IL-13 Antibody (Lebrikizumab, Research Use)
NBR-0737
M1295
IL-13
Human IL-13 Antibody (M1295, Research Use)
NBR-0738
Nofazinlimab
PDCD1
Human PDCD1 / PD-1 / CD279 Antibody (Nofazinlimab, Research Use)
NBR-0739
Novartis patent anti-CD45
PTPRC
Human PTPRC / CD45 Antibody (Novartis patent anti-CD45, Research Use)
NBR-0740
DISC0280
IL-15
Human IL-15 Antibody (DISC0280, Research Use)
NBR-0741
ABT-325
IL-18
Human IL-18 Antibody (ABT-325, Research Use)
NBR-0742
Bermekimab
IL-1a
Human IL-1a Antibody (Bermekimab, Research Use)
NBR-0743
CDP484
IL-1b
Human IL-1b Antibody (CDP484, Research Use)
NBR-0744
Novo Nordisk patent anti-Factor VIII
F8
Human F8 / Factor VIII Antibody (Novo Nordisk patent anti-Factor VIII, Research Use)
NBR-0745
Melrilimab
IL-1RL1
Human IL-1RL1 / ST2 / IL-33R Antibody (Melrilimab, Research Use)
NBR-0746
Cheng Kung U. patent anti-IL-20
IL-20
Human IL-20 Antibody (Cheng Kung U. patent anti-IL-20, Research Use)
NBR-0747
Avizakimab
IL-21
Human IL-21 Antibody (Avizakimab, Research Use)
NBR-0748
Brazikumab
IL-23
Human IL-23 Antibody (Brazikumab, Research Use)
NBR-0749
LY2525623
IL-23
Human IL-23 Antibody (LY2525623, Research Use)
NBR-0750
Mirikizumab
IL-23
Human IL-23 Antibody (Mirikizumab, Research Use)
NBR-0751
Risankizumab
IL-23
Human IL-23a Antibody (Risankizumab, Research Use)
NBR-0752
CamidanlumAb
IL-2Ra
Human IL-2Ra / CD25 Antibody (CamidanlumAb, Research Use)
NBR-0753
Ocaratuzumab
CD20
Human CD20 Antibody (Ocaratuzumab, Research Use)
NBR-0754
Ociperlimab
TIGIT
Human TIGIT Antibody (Ociperlimab, Research Use)
NBR-0755
Ocrelizumab
CD20
Human CD20 Antibody (Ocrelizumab, Research Use)
NBR-0756
Itepekimab
IL-33
Human IL-33 Antibody (Itepekimab, Research Use)
NBR-0757
Ofatumumab
CD20
Human CD20 Antibody (Ofatumumab, Research Use)
NBR-0758
MEDI2045
IL-4Ra
Human IL-4Ra / CD124 Antibody (MEDI2045, Research Use)
NBR-0759
Abgenix anti-IL-5
IL-5
Human IL-5 Antibody (Abgenix anti-IL-5, Research Use)
NBR-0760
Okayama U. patent anti-oxLDL
OLR1
Human oxLDL Antibody (Okayama U. patent anti-oxLDL, Research Use)
NBR-0761
Chugai SK2
IL-6
Human IL-6 / IFNb2 Antibody (Chugai SK2, Research Use)
NBR-0762
CSTRI patent anti-IL-6
IL-6
Human IL-6 / IFNb2 Antibody (CSTRI patent anti-IL-6, Research Use)
NBR-0763
Medarex patent anti-IL-6
IL-6
Human IL-6 / IFNb2 Antibody (Medarex patent anti-IL-6, Research Use)
NBR-0764
MEDI 5117
IL-6
Human IL-6 / IFNb2 Antibody (MEDI 5117, Research Use)
NBR-0765
Merck patent anti-IL-6
IL-6
Human IL-6 / IFNb2 Antibody (Merck patent anti-IL-6, Research Use)
NBR-0766
Olinvacimab
KDR
Human VEGFR2 / KDR / CD309 Antibody (Olinvacimab, Research Use)
NBR-0767
Siltuximab
IL-6
Human IL-6 / IFNb2 Antibody (Siltuximab, Research Use)
NBR-0768
Sirukumab
IL-6
Human IL-6 / IFNb2 Antibody (Sirukumab, Research Use)
NBR-0769
Ziltivekimab
IL-6
Human IL-6 / IFNb2 Antibody (Ziltivekimab, Research Use)
NBR-0770
APX007
IL-6Ra
Human IL-6Ra / CD126 Antibody (APX007, Research Use)
NBR-0771
Levilimab
IL-6Ra
Human IL-6Ra / CD126 Antibody (Levilimab, Research Use)
NBR-0772
Sapelizumab
IL-6Ra
Human IL-6Ra / CD126 Antibody (Sapelizumab, Research Use)
NBR-0773
Olokizumab
IL-6
Human IL-6 / IFNb2 Antibody (Olokizumab, Research Use)
NBR-0774
Omalizumab
IGHE
Human IgE Antibody (Omalizumab, Research Use)
NBR-0775
Omburtamab
CD276
Human B7-H3 / CD276 Antibody (Omburtamab, Research Use)
NBR-0776
PF-06342674
IL-7Ra
Human IL-7Ra / CD127 Antibody (PF-06342674, Research Use)
NBR-0777
Ongericimab
PCSK9
Human PCSK9 Antibody (Ongericimab, Research Use)
NBR-0778
Vatelizumab
ITGA2 & ITGB1
Human Integrin a2b1 (ITGA2 & ITGB1) Antibody (Vatelizumab, Research Use)
NBR-0779
BMS patent anti-Integrin α5β1
ITGA5 & ITGB1
Human Integrin a5b1 (ITGA5 & ITGB1) Antibody (BMS patent anti-Integrin α5β1, Research Use)
NBR-0780
Efalizumab
 ITGAL
Human Integrin aL / ITGAL / CD11a Antibody (Efalizumab, Research Use)
NBR-0781
Abituzumab
ITGAV
Human Integrin aV / ITGAV / CD51 Antibody (Abituzumab, Research Use)
NBR-0782
Intetumumab
ITGAV
Human Integrin aV / ITGAV / CD51 Antibody (Intetumumab, Research Use)
NBR-0783
Etaracizumab
ITGAV & ITGB3
Human Integrin aVb3 (ITGAV & ITGB3) Antibody (Etaracizumab, Research Use)
NBR-0784
Opicinumab
 LINGO1
Human LINGO1 Antibody (Opicinumab, Research Use)
NBR-0785
Oportuzumab
 EPCAM
Human EpCAM / TROP1 / CD326 Antibody (Oportuzumab, Research Use)
NBR-0786
Encelimab
LAG3
Human LAG3 / CD223 Antibody (Encelimab, Research Use)
NBR-0787
Favezelimab
LAG3
Human LAG3 / CD223 Antibody (Favezelimab, Research Use)
NBR-0788
Fianlimab
LAG3
Human LAG3 / CD223 Antibody (Fianlimab, Research Use)
NBR-0789
Ieramilimab
LAG3
Human LAG3 / CD223 Antibody (Ieramilimab, Research Use)
NBR-0790
Miptenalimab
LAG3
Human LAG3 / CD223 Antibody (Miptenalimab, Research Use)
NBR-0791
Opucolimab
 CD274
Human B7-H1 / PD-L1 / CD274 Antibody (Opucolimab, Research Use)
NBR-0792
LadiratuzumAb
 SLC39A6
Human LIV-1 / SLC39A6 Antibody (LadiratuzumAb, Research Use)
NBR-0793
Organon patent anti-CD27
 CD27
Human TNFRSF7 / CD27 Antibody (Organon patent anti-CD27, Research Use)
NBR-0794
Orilanolimab
FCGRT
Human FcRn (FCGRT & B2M) Antibody (Orilanolimab, Research Use)
NBR-0795
Orticumab
OLR1
Human oxLDL Antibody (Orticumab, Research Use)
NBR-0796
ORY012
AXL
Human AXL / UFO Antibody (ORY012, Research Use)
NBR-0797
BMS-986148
MSLN
Human Mesothelin Antibody (BMS-986148, Research Use)
NBR-0798
Osocimab
F11
Human F11 / Factor XI Antibody (Osocimab, Research Use)
NBR-0799
Yeda patent anti-MMP-9
MMP9
Human MMP9 Antibody (Yeda patent anti-MMP-9, Research Use)
NBR-0800
Otelixizumab
 CD3E
Human CD3 Antibody (Otelixizumab, Research Use)
NBR-0801
Otilimab
CSF2
Human CSF2 / GM-CSF Antibody (Otilimab, Research Use)
NBR-0802
AR20.5
 MUC1
Human MUC1 Antibody (AR20.5, Research Use)
NBR-0803
Otlertuzumab
CD37
Human TSPAN26 / CD37 Antibody (Otlertuzumab, Research Use)
NBR-0804
Oxford Brookes U. patent anti-Activin Beta-B
INHBB
Human INHBB / Activin B Antibody (Oxford Brookes U. patent anti-Activin Beta-B, Research Use)
NBR-0805
Imaprelimab
 MCAM
Human MUC18 / MCAM / CD146 Antibody (Imaprelimab, Research Use)
NBR-0806
AS2886401-00
NGF
Human NGF / bNGF Antibody (AS2886401-00, Research Use)
NBR-0807
Fasinumab
NGF
Human NGF / bNGF Antibody (Fasinumab, Research Use)
NBR-0808
MEDI-578
NGF
Human NGF / bNGF Antibody (MEDI-578, Research Use)
NBR-0809
PG110
NGF
Human NGF / bNGF Antibody (PG110, Research Use)
NBR-0810
Uliledlimab
NT5E
Human NT5E / CD73 Antibody (Uliledlimab, Research Use)
NBR-0811
Pfizer patent anti-Notch1
NOTCH1
Human NOTCH1 Antibody (Pfizer patent anti-Notch1, Research Use)
NBR-0812
Vixarelimab
OSMR
Human OSMR Antibody (Vixarelimab, Research Use)
NBR-0813
ASK8007
 SPP1
Human Osteopontin Antibody (ASK8007, Research Use)
NBR-0814
Plonmarlimab
CSF2
Human CSF2 / GM-CSF Antibody (Plonmarlimab, Research Use)
NBR-0815
Ponezumab
 APP
Human Amyloid Beta Antibody (Ponezumab, Research Use)
NBR-0816
Zelminemab
PAC1
Human PAC1 Antibody (Zelminemab, Research Use)
NBR-0817
Ponsegromab
 GDF15
Human GDF15 / MIC-1 Antibody (Ponsegromab, Research Use)
NBR-0818
Amgen patent anti-PAR-2
PAR2
Human PAR2 Antibody (Amgen patent anti-PAR-2, Research Use)
NBR-0819
Pozelimab
C5
Human Complement C5 Antibody (Pozelimab, Research Use)
NBR-0820
U.Penn. patent anti-PCLA
PLCA
Human PCLA Antibody (U.Penn. patent anti-PCLA, Research Use)
NBR-0821
Prolgolimab
PDCD1
Human PDCD1 / PD-1 / CD279 Antibody (Prolgolimab, Research Use)
NBR-0822
Quark patent anti-ENDO 180
 MRC2
Human MRC2 / CD280 Antibody (Quark patent anti-ENDO 180, Research Use)
NBR-0823
Quavonlimab
 CTLA4
Human CTLA-4 / CD152  Antibody (Quavonlimab, Research Use)
NBR-0824
Racotumomab
ST3GAL5
Human GM3 Antibody (Racotumomab, Research Use)
NBR-0825
Merck patent anti-PCSK9
PCSK9
Human PCSK9 Antibody (Merck patent anti-PCSK9, Research Use)
NBR-0826
Ralpancizumab
PCSK9
Human PCSK9 Antibody (Ralpancizumab, Research Use)
NBR-0827
Recaticimab
PCSK9
Human PCSK9 Antibody (Recaticimab, Research Use)
NBR-0828
RG7652
PCSK9
Human PCSK9 Antibody (RG7652, Research Use)
NBR-0829
Schering patent anti-PCSK9
PCSK9
Human PCSK9 Antibody (Schering patent anti-PCSK9, Research Use)
NBR-0830
Regeneron patent anti-ASIC1
 ASIC1
Human ASIC1 Antibody (Regeneron patent anti-ASIC1, Research Use)
NBR-0831
Balstilimab
PDCD1
Human PDCD1 / PD-1 / CD279 Antibody (Balstilimab, Research Use)
NBR-0832
Budigalimab
PDCD1
Human PDCD1 / PD-1 / CD279 Antibody (Budigalimab, Research Use)
NBR-0833
Cetrelimab
PDCD1
Human PDCD1 / PD-1 / CD279 Antibody (Cetrelimab, Research Use)
NBR-0834
Regeneron patent anti-CD20
CD20
Human CD20 Antibody (Regeneron patent anti-CD20, Research Use)
NBR-0835
Ezabenlimab
PDCD1
Human PDCD1 / PD-1 / CD279 Antibody (Ezabenlimab, Research Use)
NBR-0836
Regeneron patent anti-EGFR
ERBB1
Human ERBB1 / EGFR / HER1 Antibody (Regeneron patent anti-EGFR, Research Use)
NBR-0837
Regeneron patent anti-PAR-2
PAR2
Human PAR2 Antibody (Regeneron patent anti-PAR-2, Research Use)
NBR-0838
Penpulimab
PDCD1
Human PDCD1 / PD-1 / CD279 Antibody (Penpulimab, Research Use)
NBR-0839
Pidilizumab
PDCD1
Human PDCD1 / PD-1 / CD279 Antibody (Pidilizumab, Research Use)
NBR-0840
Pimivalimab
PDCD1
Human PDCD1 / PD-1 / CD279 Antibody (Pimivalimab, Research Use)
NBR-0841
Retifanlimab
PDCD1
Human PDCD1 / PD-1 / CD279 Antibody (Retifanlimab, Research Use)
NBR-0842
Sasanlimab
PDCD1
Human PDCD1 / PD-1 / CD279 Antibody (Sasanlimab, Research Use)
NBR-0843
Serplulimab
PDCD1
Human PDCD1 / PD-1 / CD279 Antibody (Serplulimab, Research Use)
NBR-0844
Sintilimab
PDCD1
Human PDCD1 / PD-1 / CD279 Antibody (Sintilimab, Research Use)
NBR-0845
Tislelizumab
PDCD1
Human PDCD1 / PD-1 / CD279 Antibody (Tislelizumab, Research Use)
NBR-0846
UCB patent anti-PD-1
PDCD1
Human PDCD1 / PD-1 / CD279 Antibody (UCB patent anti-PD-1, Research Use)
NBR-0847
Zimberelimab
PDCD1
Human PDCD1 / PD-1 / CD279 Antibody (Zimberelimab, Research Use)
NBR-0848
Revdofilimab
TNFRSF4
Human TNFRSF4 / OX40 / CD134 Antibody (Revdofilimab, Research Use)
NBR-0849
RO5458640
TNFSF12
Human TNFSF12 / TWEAK Antibody (RO5458640, Research Use)
NBR-0850
IMC-2C5
 PDGFRB
Human PDGFRB / CD140b Antibody (IMC-2C5, Research Use)
NBR-0851
Robatumumab
IGF1R
Human IGF1R / CD221 Antibody (Robatumumab, Research Use)
NBR-0852
Bavituximab
N/A
Human Phosphatidylserine Antibody (Bavituximab, Research Use)
NBR-0853
Roche patent anti-ANG-2
ANGPT2
Human ANGPT2 Antibody (Roche patent anti-ANG-2, Research Use)
NBR-0854
Roche patent anti-CCN1
 CCN1
Human CYR61 / CCN1 Antibody (Roche patent anti-CCN1, Research Use)
NBR-0855
BAY 1158061
PRLR
Human PRLR / Prolactin Receptor Antibody (BAY 1158061, Research Use)
NBR-0856
Rockefeller U. patent anti-Amyloid Beta
 APP
Human Amyloid Beta Antibody (Rockefeller U. patent anti-Amyloid Beta, Research Use)
NBR-0857
Roledumab
CD240d
Human RHD / CD240d Antibody (Roledumab, Research Use)
NBR-0858
Medella patent anti-RAMP-3
 RAMP3
Human RAMP3 Antibody (Medella patent anti-RAMP-3, Research Use)
NBR-0859
LFB Anti-RhD
CD240d
Human RHD / CD240d Antibody (LFB Anti-RhD, Research Use)
NBR-0860
Atinumab
RTN4
Human RTN4 / NOGO Antibody (Atinumab, Research Use)
NBR-0861
NG-101
RTN4
Human RTN4 / NOGO Antibody (NG-101, Research Use)
NBR-0862
LK-1
 S100A4
Human S100A4 Antibody (LK-1, Research Use)
NBR-0863
SBI Biotech patent anti-BST2
 BST2
Human BST2 / CD317 Antibody (SBI Biotech patent anti-BST2, Research Use)
NBR-0864
AB-25E9
 SIGLEC15
Human Siglec-15 / CD33L3 Antibody (AB-25E9, Research Use)
NBR-0865
Medimmune patent anti-Siglec-15
 SIGLEC15
Human Siglec-15 / CD33L3 Antibody (Medimmune patent anti-Siglec-15, Research Use)
NBR-0866
Epratuzumab
 CD22
Human Siglec-2 / CD22 Antibody (Epratuzumab, Research Use)
NBR-0867
NCI m971
 CD22
Human Siglec-2 / CD22 Antibody (NCI m971, Research Use)
NBR-0868
NCI m972
 CD22
Human Siglec-2 / CD22 Antibody (NCI m972, Research Use)
NBR-0869
Pinatuzumab
 CD22
Human Siglec-2 / CD22 Antibody (Pinatuzumab, Research Use)
NBR-0870
IMGN779
 CD22
Human Siglec-3 / CD33 Antibody (IMGN779, Research Use)
NBR-0871
AzintuxizumAb
 SLAMF7
Human SLAMF7 / CS1 Antibody (AzintuxizumAb, Research Use)
NBR-0872
PDL241
 SLAMF7
Human SLAMF7 / CS1 Antibody (PDL241, Research Use)
NBR-0873
VB1-050
SLC2A8
Human SLC2A8 Antibody (VB1-050, Research Use)
NBR-0874
LifastuzumAb
SLC34A2
Human SLC34A2 Antibody (LifastuzumAb, Research Use)
NBR-0875
Upifitamab
SLC34A2
Human SLC34A2 Antibody (Upifitamab, Research Use)
NBR-0876
Solanezumab
 APP
Human Amyloid Beta Antibody (Solanezumab, Research Use)
NBR-0877
Sonepcizumab
SGPP1
Human Sphingosine-1-phosphate Antibody (Sonepcizumab, Research Use)
NBR-0878
Tadocizumab
ITGA2 & ITGB3
Human Integrin a2b3 (ITGA2 & ITGB3) Antibody (Tadocizumab, Research Use)
NBR-0879
Bepranemab
MAPT
Human Tau Antibody (Bepranemab, Research Use)
NBR-0880
Tafolecimab
PCSK9
Human PCSK9 Antibody (Tafolecimab, Research Use)
NBR-0881
LY3022859
 TGFBR2
Human TBFbR2 Antibody (LY3022859, Research Use)
NBR-0882
NKTT320
PTCRA
Human TCR Antibody (NKTT320, Research Use)
NBR-0883
Telazorlimab
TNFRSF4
Human TNFRSF4 / OX40 / CD134 Antibody (Telazorlimab, Research Use)
NBR-0884
Tenatumomab
 TNC
Human Tenascin C Antibody (Tenatumomab, Research Use)
NBR-0885
Marstacimab
 TFPI
Human TFPI Antibody (Marstacimab, Research Use)
NBR-0886
NIS793
TGFB1
Human TGFb1 Antibody (NIS793, Research Use)
NBR-0887
Zampilimab
TGM2
Human TGM2 / Transglutaminase 2 Antibody (Zampilimab, Research Use)
NBR-0888
Etigilimab
 TIGIT
Human TIGIT Antibody (Etigilimab, Research Use)
NBR-0889
Tesidolumab
C5
Human Complement C5 Antibody (Tesidolumab, Research Use)
NBR-0890
Theraclone patent anti-GM-CSF
CSF2
Human CSF2 / GM-CSF Antibody (Theraclone patent anti-GM-CSF, Research Use)
NBR-0891
Tilavonemab
MAPT
Human Tau Antibody (Tilavonemab, Research Use)
NBR-0892
Chugai patent anti-TF
TF
Human Tissue factor / CD142 Antibody (Chugai patent anti-TF, Research Use)
NBR-0893
Tilogotamab
 TNFRSF10B
Human TNFRSF10B / TRAILR2 / CD262 Antibody (Tilogotamab, Research Use)
NBR-0894
TNX-832
TF
Human Tissue factor / CD142 Antibody (TNX-832, Research Use)
NBR-0895
Benufutamab
 TNFRSF10B
Human TNFRSF10B / TRAILR2 / CD262 Antibody (Benufutamab, Research Use)
NBR-0896
TOL101
PTCRA
Human TCR Antibody (TOL101, Research Use)
NBR-0897
Lexatumumab
 TNFRSF10B
Human TNFRSF10B / TRAILR2 / CD262 Antibody (Lexatumumab, Research Use)
NBR-0898
Tomuzotuximab
ERBB1
Human ERBB1 / EGFR / HER1 Antibody (Tomuzotuximab, Research Use)
NBR-0899
Toray patent anti-Caprin-1
CAPRIN1
Human CAPRIN1 Antibody (Toray patent anti-Caprin-1, Research Use)
NBR-0900
Toripalimab
PDCD1
Human PDCD1 / PD-1 / CD279 Antibody (Toripalimab, Research Use)
NBR-0901
BMS-986178
TNFRSF4
Human TNFRSF4 / OX40 / CD134 Antibody (BMS-986178, Research Use)
NBR-0902
Torudokimab
IL-33
Human IL-33 Antibody (Torudokimab, Research Use)
NBR-0903
Tozorakimab
IL-33
Human IL-33 Antibody (Tozorakimab, Research Use)
NBR-0904
U.Illinois scFv59
 APP
Human Amyloid Beta Antibody (U.Illinois scFv59, Research Use)
NBR-0905
Iscalimab
CD40
Human TNFRSF5 / CD40 Antibody (Iscalimab, Research Use)
NBR-0906
Lucatumumab
CD40
Human TNFRSF5 / CD40 Antibody (Lucatumumab, Research Use)
NBR-0907
Mitazalimab
CD40
Human TNFRSF5 / CD40 Antibody (Mitazalimab, Research Use)
NBR-0908
Ravagalimab
CD40
Human TNFRSF5 / CD40 Antibody (Ravagalimab, Research Use)
NBR-0909
U.Rochester patent anti-DC-STAMP
DCSTAMP
Human DCSTAMP Antibody (U.Rochester patent anti-DC-STAMP, Research Use)
NBR-0910
Pateclizumab
TNFSF1
Human TNFSF1 / TNFb Antibody (Pateclizumab, Research Use)
NBR-0911
U.Washington patent anti-GAD65
GAD2
Human GAD65 Antibody (U.Washington patent anti-GAD65, Research Use)
NBR-0912
U.Washington patent anti-MICB
MICB
Human MICB Antibody (U.Washington patent anti-MICB, Research Use)
NBR-0913
Sibeprenlimab
TNFSF13
Human TNFSF13 / APRIL / CD256 Antibody (Sibeprenlimab, Research Use)
NBR-0914
Tabalumab
 TNFSF13B
Human TNFSF13B / BAFF / CD257 Antibody (Tabalumab, Research Use)
NBR-0915
SAR252067
 TNFSF14
Human TNFSF14 / LIGHT / CD258 Antibody (SAR252067, Research Use)
NBR-0916
CDP571
TNFSF2
Human TNFSF2 / TNFa Antibody (CDP571, Research Use)
NBR-0917
U.Zurich patent anti-Amyloid Beta
 APP
Human Amyloid Beta Antibody (U.Zurich patent anti-Amyloid Beta, Research Use)
NBR-0918
CMAB008
TNFSF2
Human TNFSF2 / TNFa Antibody (CMAB008, Research Use)
NBR-0919
ESBA 105
TNFSF2
Human TNFSF2 / TNFa Antibody (ESBA 105, Research Use)
NBR-0920
HMAK195
TNFSF2
Human TNFSF2 / TNFa Antibody (HMAK195, Research Use)
NBR-0921
Vedolizumab
 ITGA4 & ITGB7
Human Integrin a4b7 (ITGA4 & ITGB7) Antibody (Vedolizumab, Research Use)
NBR-0922
Ruplizumab
CD40LG
Human TNFSF5 / CD40L / CD154 Antibody (Ruplizumab, Research Use)
NBR-0923
Vibostolimab
TIGIT
Human TIGIT Antibody (Vibostolimab, Research Use)
NBR-0924
Vilobelimab
C5
Human Complement C5 Antibody (Vilobelimab, Research Use)
NBR-0925
Wyeth patent anti-5T4
TPBG
Human TPBG Antibody (Wyeth patent anti-5T4, Research Use)
NBR-0926
Rinat patent anti-TrkB
 NTRK2
Human TrkB / NTRK2 Antibody (Rinat patent anti-TrkB, Research Use)
NBR-0927
Schering patent anti-TSLP
TSLP
Human TSLP Antibody (Schering patent anti-TSLP, Research Use)
NBR-0928
AGS67E
CD37
Human TSPAN26 / CD37 Antibody (AGS67E, Research Use)
NBR-0929
Volociximab
ITGA5 & ITGB1
Human Integrin a5b1 (ITGA5 & ITGB1) Antibody (Volociximab, Research Use)
NBR-0930
Vonlerizumab
TNFRSF4
Human TNFRSF4 / OX40 / CD134 Antibody (Vonlerizumab, Research Use)
NBR-0931
Hanwha patent anti-VCAM-1
 VCAM1
Human VCAM1 / CD106 Antibody (Hanwha patent anti-VCAM-1, Research Use)
NBR-0932
Zagotenemab
MAPT
Human Tau Antibody (Zagotenemab, Research Use)
NBR-0933
Ranibizumab
VEGFA
Human VEGFA Antibody (Ranibizumab, Research Use)
NBR-0934
Varisacumab
VEGFA
Human VEGFA Antibody (Varisacumab, Research Use)
NBR-0935
VGX100
VEGFC
Human VEGFC Antibody (VGX100, Research Use)
NBR-0936
AlacizumAb
KDR
Human VEGFR2 / KDR / CD309 Antibody (AlacizumAb, Research Use)
NBR-0937
AT001
KDR
Human VEGFR2 / KDR / CD309 Antibody (AT001, Research Use)
NBR-0938
Vulinacimab
KDR
Human VEGFR2 / KDR / CD309 Antibody (Vulinacimab, Research Use)
NBR-0939
LY3022856
 FLT4
Human VEGFR3 / FLT4 Antibody (LY3022856, Research Use)
NBR-0940
Bapineuzumab
 APP
Human Amyloid Beta Antibody (Bapineuzumab, Research Use)
NBR-0941
Lecanemab
 APP
Human Amyloid Beta Antibody (Lecanemab, Research Use)
NBR-0942
Antitope patent anti-CTLA4
CD152
Human CTLA-4 / CD152 Antibody (Antitope patent anti-CTLA4, Research Use)
NBR-0943
BioMab patent anti-Her2
ERBB2
Human ERBB2 / HER2 / CD340 Antibody (BioMab patent anti-Her2, Research Use)
NBR-0944
BioMab patent anti-VEGF
VEGFA
Human VEGF Antibody (BioMab patent anti-VEGF, Research Use)
NBR-0945
Centocor patent anti-GLP-1R
 GLP1R
Human GLP1R Antibody (Centocor patent anti-GLP-1R, Research Use)
NBR-0946
Axatilimab
CSF1R
Human CSF1R / M-CSFR / CD115 Antibody (Axatilimab, Research Use)
NBR-0947
Immunomedics patent anti-CEACAM5 (Class III)
CD66a
Human CEACAM5 / CEA / CD66e Antibody (Immunomedics patent anti-CEACAM5 (Class III), Research Use)
NBR-0948
Naxitamab
 
Human GD2 Antibody (Naxitamab, Research Use)
NBR-0949
Medarex patent anti-IFNAR-1
IFNAR1
Human IFNARa1 Antibody (Medarex patent anti-IFNAR-1, Research Use)
NBR-0950
Obexelimab
CD19
Human CD19 Antibody (Obexelimab, Research Use)
NBR-0951
Genzyme patent anti-TGF-β
TGFB1
Human TGFb1 Antibody (Genzyme patent anti-TGF-β, Research Use)
NBR-0952
Tezepelumab
TSLP
Human TSLP Antibody (Tezepelumab, Research Use)
NBR-0953
IgG1+Kappa Isotype Control
ABM
Human Abm Antibody (IgG1+Kappa Isotype Control, Research Use)
NBR-0954
IgG4+Kappa Isotype Control
ABM
Human Abm Antibody (IgG4+Kappa Isotype Control, Research Use)
NBR-0955
Pritoxaximab
Shiga toxin (E.coli)
Human Shiga toxin (E.coli) Antibody (Pritoxaximab, Research Use)
NBR-0956
Setoxaximab
Shiga toxin (E.coli)
Human Shiga toxin (E.coli) Antibody (Setoxaximab, Research Use)
NBR-0957
OST 577
HBsAg
Human HBsAg Antibody (OST 577, Research Use)
NBR-0958
Foravirumab
Rabies virus GP
Human Rabies virus GP Antibody (Foravirumab, Research Use)
NBR-0959
Rafivirumab
Rabies virus GP
Human Rabies virus GP Antibody (Rafivirumab, Research Use)
NBR-0960
Motavizumab
RSV-F
Human RSV-F Antibody (Motavizumab, Research Use)
NBR-0961
Palivizumab
RSV-F
Human RSV-F Antibody (Palivizumab, Research Use)
NBR-0962
Metelimumab
TGFB1
Human TGFB1 Antibody (Metelimumab, Research Use)
NBR-0963
Bimekizumab
CTLA-8
Human IL17A, IL-17F, IL17AF Antibody (Bimekizumab, Research Use)
NBR-0964
Panitumumab
VEGF
Human EGFR Antibody (Panitumumab, Research Use)
NBR-0965
Datopotamab
 TACSTD2
Human TROP2 Antibody (Datopotamab, Research Use)
NBR-0966
Praluzatamab-MMAE
ALCAM / CD166
Anti-ALCAM / CD166 Reference Antibody (Praluzatamab-MMAE)
NBR-1000
Murlentamab-MMAE
AMHR2
Anti-AMHR2 Reference Antibody (Murlentamab-MMAE)
NBR-1001
Enapotamab vedotin
AXL / UFO
Anti-AXL / UFO Reference Antibody (Enapotamab vedotin)
NBR-1002
Tilvestamab-MMAE
AXL / UFO
Anti-AXL / UFO Reference Antibody (Tilvestamab-MMAE)
NBR-1003
oregovomab-MMAE
CA125 / MUC16
Anti-MUC16 Reference Antibody (oregovomab-MMAE)
NBR-1004
Sofituzumab vedotin
CA125 / MUC16
Anti-MUC16 Reference Antibody (Sofituzumab vedotin)
NBR-1005
girentuximab-MMAE
CA9 / Carbonic anhydrase 9
Anti-CA9 / CAIX Reference Antibody (girentuximab-MMAE)
NBR-1006
denintuzumab-MMAF
CD19
Anti-CD19 Reference Antibody (denintuzumab-MMAF)
NBR-1007
Polatuzumab vedotin-piiq
CD79b
Anti-CD79b Reference Antibody (Polatuzumab vedotin-piiq)
NBR-1008
iladatuzumab vedotin
CD79b
Anti-CD79b Reference Antibody (iladatuzumab vedotin)
NBR-1009
labetuzumab govitecan
CEACAM5 / CEA / CD66e
Anti-CEACAM5 / CEA / CD66e Reference Antibody (labetuzumab govitecan)
NBR-1010
Tusamitamab-MMAE
CEACAM5 / CEA / CD66e
Anti-CEACAM5 / CEA / CD66e Reference Antibody (Tusamitamab-MMAE)
NBR-1011
zolbetuximab MMAE
CLDN18.2
Anti-CLDN18.2 Reference Antibody (zolbetuximab MMAE)
NBR-1012
ulocuplumab-MMAE
CXCR4 / CD184
Anti-CXCR4/CD184 Reference Antibody (ulocuplumab-MMAE)
NBR-1013
rovalpituzumab-MMAE
DLL3
Anti-DLL3 Reference Antibody (rovalpituzumab-MMAE)
NBR-1014
carotuximab-MMAE
Endoglin / CD105
Anti-Endoglin / CD105 Reference Antibody (carotuximab-MMAE)
NBR-1015
depatuxizumab-MMAF
ERBB1 / EGFR / HER1
Anti-ERBB1 / EGFR / HER1 Reference Antibody (depatuxizumab-MMAF)
NBR-1016
Cetuximab-MMAE
ERBB1 / EGFR / HER1
Anti-ERBB1 / EGFR / HER1 Reference Antibody (Cetuximab-MMAE)
NBR-1017
Disitamab vedotin
ERBB2 / HER2 / CD340
Anti-ERBB2 / HER2 / CD340 Reference Antibody (Disitamab vedotin)
NBR-1018
Trastuzumab-MMAE
ERBB2 / HER2 / CD340
Anti-ERBB2 / HER2 / CD340 Reference Antibody (Trastuzumab-MMAE)
NBR-1019
patritumab-MMAE
ERBB3 / HER3
Anti-ERBB3/ HER3 Reference Antibody (patritumab-MMAE)
NBR-1020
Patritumab deruxtecan
ERBB3 / HER3
Anti-ERBB3/ HER3 Reference Antibody (Patritumab deruxtecan)
NBR-1021
rosopatamab-MMAE
FOLH1 / PSMA
Anti-FOLH1 / PSMA Reference Antibody (rosopatamab-MMAE)
NBR-1022
farletuzumab-MMAE
FOLR1 / FRA
Anti-FOLR1 / FRA Reference Antibody (farletuzumab-MMAE)
NBR-1023
mirvetuximab-MMAE
FOLR1 / FRA
Anti-FOLR1 / FRA Reference Antibody (mirvetuximab-MMAE)
NBR-1024
ecromeximab-MMAE
GD3
Anti-GD3 Reference Antibody (ecromeximab-MMAE)
NBR-1025
Codrituzumab-MMAE
GPC3 / Glypican-3
Anti-GPC3 / Glypican-3 Reference Antibody (Codrituzumab-MMAE)
NBR-1026
Glembatumumab vedotin
GPNMB
Anti-GPNMB Reference Antibody (Glembatumumab vedotin)
NBR-1027
Indusatumab vedotin
GUCY2C
Anti-GUCY2C Reference Antibody (Indusatumab vedotin)
NBR-1028
Telisotuzumab vedotin
HGFR / c-Met
Anti-HGFR / c-Met Reference Antibody (Telisotuzumab vedotin)
NBR-1029
talacotuzumab-MMAE
IL-3Ra / CD123
Anti-IL-3Ra / CD123 Reference Antibody (talacotuzumab-MMAE)
NBR-1030
ADCT-901-MMAE
KAAG1
Anti-KAAG1 Reference Antibody (ADCT-901-MMAE)
NBR-1031
Ladiratuzumab vedotin
LIV-1 / SLC39A6
Anti-LIV-1 / SLC39A6 Reference Antibody (Ladiratuzumab vedotin)
NBR-1032
anetumab-MMAE
Mesothelin
Anti-Mesothelin Reference Antibody (anetumab-MMAE)
NBR-1033
ensituximab-MMAE
MU5AC
Anti-MU5AC Reference Antibody (ensituximab-MMAE)
NBR-1034
clivatuzumab-MMAE
MUC1
Anti-MUC1 Reference Antibody (clivatuzumab-MMAE)
NBR-1035
Lifastuzumab vedotin
NaPi2b / SLC34A2
Anti-NaPi2b / SLC34A2 Reference Antibody (Lifastuzumab vedotin)
NBR-1036
lorvotuzumab-MMAE
NCAM1 / CD56
Anti-NCAM1 / CD56 Reference Antibody (lorvotuzumab-MMAE)
NBR-1037
enfortumab vedotin-ejfv
Nectin-4
Anti-Nectin-4 Reference Antibody (enfortumab vedotin-ejfv)
NBR-1038
Zilovertamab vedotin
ROR1
Anti-ROR1 Reference Antibody (Zilovertamab vedotin)
NBR-1039
ozuriftamab vedotin
ROR2
Anti-ROR2 Reference Antibody (ozuriftamab vedotin)
NBR-1040
Pinatuzumab vedotin
Siglec-2 / CD22
Anti-Siglec-2 / CD22 Reference Antibody (Pinatuzumab vedotin)
NBR-1041
inotuzumab-MMAE
Siglec-2 / CD22
Anti-Siglec-2 / CD22 Reference Antibody (inotuzumab-MMAE)
NBR-1042
Sirtratumab vedotin
SLITRK6
Anti-SLITRK6 Reference Antibody (Sirtratumab vedotin)
NBR-1043
tisotumab vedotin
TF / Factor III / Tissue Factor / CD142
Anti-TF / Factor III / Tissue Factor / CD142 Reference Antibody (tisotumab vedotin)
NBR-1044
brentuximab vedotin
TNFRSF8 / CD30
Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin)
NBR-1045
Vorsetuzumab mafodotin
TNFSF7 / CD27L / CD70
Anti-TNFSF7 / CD27L / CD70 Reference Antibody (Vorsetuzumab mafodotin)
NBR-1046
datopotamab deruxtecan
TROP2
Anti-TROP2 Reference Antibody (datopotamab deruxtecan)
NBR-1047
Sacituzumab-MMAE
TROP2
Anti-TROP2 Reference Antibody (Sacituzumab-MMAE)
NBR-1048

 

关键词:Alpha-fetoprotein抗体,CD19抗体,CD28抗体,CD40抗体,CD40L抗体,CD70抗体,B7-2抗体,CDK4抗体,CEACAM-5抗体,CTLA-4抗体,IL-8抗体,VEGFR2抗体,KRAS抗体,LAG-3抗体,TNFRSF5抗体,TNFSF5抗体,CD27抗体,CD86抗体,CD66e抗体,CXCL8抗体,KDR抗体,Anti-Alpha-fetoprotein,Anti-CD19,Anti-CD28,Anti-CD40,Anti-CD40L,Anti-CD70,Anti-B7-2,Anti-CDK4,Anti-CEACAM-5,Anti-CTLA-4,Anti-IL-8,Anti-VEGFR2,Anti-KRAS,Anti-LAG-3,Anti-TNFRSF5,Anti-TNFSF5,Anti-CD27,Anti-CD86,Anti-CD66e,Anti-CXCL8,Anti-KDR,抗Alpha-fetoprotein单抗,抗CD19单抗,抗CD28单抗,抗CD40单抗,抗CD40L单抗,抗CD70单抗,抗B7-2单抗,抗CDK4单抗,抗CEACAM-5单抗,抗CTLA-4单抗,抗IL-8单抗,抗VEGFR2单抗,抗KRAS单抗,抗LAG-3单抗,抗TNFRSF5单抗,抗TNFSF5单抗,抗CD27单抗,抗CD86单抗,抗CD66e单抗,抗CXCL8单抗,抗KDR单抗

 

相关新闻资讯

辰辉创聚生物Nebulabio药物抗体研究用标准品

2025/02/21

辰辉创聚生物Nebulabio提供多种药物抗体研究用标准品 获取更多信息https://nebulabio.cn/index.php/premium/43599.html 抗体药及分子结构 抗体药是指利用人工合成的抗体或经过改造的抗体片段来治疗疾病的药物。抗体药的作用机制主要包括:直接攻击病原体或异常细胞、阻断信号通路、调节免疫系统反应等

Nebulabio Offers Series of Drug Antibody References

2025/02/21

Nebulabio Offers Series of Drug Antibody References Learn Morehttps://nebulabio.cn/en/index.php/hot/20632.html Drug Antibody Its Structure Drug Antibody, also known as t

Nebulabio Offers Series of Peptide Drug Reference Standards

2025/02/20

Nebulabio Offers Series of Peptide Drug Reference Standards Peptide Drug Peptide Peptides are compounds formed by multiple amino acids linked together through pepti